Document:

Document

	
			
	
	 
	Exhibit 10.17

FORESCOUT TECHNOLOGIES, INC. 
EMPLOYMENT AGREEMENT
This Employment Agreement (“Agreement”) is entered into by and between ForeScout Technologies, Inc., a Delaware corporation (the “Company”), and Darren J. Milliken (“Executive,” and collectively referred to as the “Parties”) effective as of January 1, 2017 (the “Effective Date”).
WHEREAS, Executive is employed with the Company.
WHEREAS, the Parties previously entered into an Employment Agreement dated January 29, 2014, as amended on March 16, 2015 (the “Prior Agreement”).
WHEREAS, the Company desires to continue to employ Executive and Executive desires to continue to be employed by the Company on the terms of this Agreement.
NOW, THEREFORE, in consideration of the mutual covenants and agreements contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:

1.    EMPLOYMENT.
1.1    Term.  As of the Effective Date, Executive agrees to continue employment with the Company pursuant to the terms of this Agreement.  This Agreement shall have an initial term beginning on the Effective Date and expiring on December 31, 2019 (the “Initial Employment Term”).  On the last day of the Initial Employment Term, this Agreement will renew automatically for additional, successive one year terms (each, a “Renewal Term”) unless one Party provides the other Party with written notice of non-renewal at least 30 days prior to the date of automatic renewal, in which case this Agreement will expire at the end of the Initial Employment Term or Renewal Term, as applicable (the Initial Employment Term and any successive Renewal Terms during which this Agreement remains in effect, collectively, the “Term”).  Non-renewal at the end of the Initial Employment Term or a Renewal Term shall constitute neither a termination without Cause (as defined below) nor a resignation for Good Reason (as defined below) under this Agreement.  In the event that a Change in Control (as defined below) occurs during the Term, the Term automatically will be extended for a period of 12 months following the Change in Control.  In addition, to the extent that a definitive agreement for a transaction that, if consummated, would result in a Change in Control has been signed, the Company may not give a Notice of Non-Renewal until after the Change in Control has occurred or such definitive agreement has been terminated in accordance with its terms.  Upon the termination of Executive’s employment with the Company, Executive will resign from all directorships, offices, and other positions that Executive may hold in the Company and all of its affiliates, unless otherwise agreed to by the Company.
1.2    Position and Duties.
1.2.1    Executive Position.  As of the Effective Date, Executive agrees to serve as Senior Vice President, General  Counsel, Corporate Secretary & Corporate Compliance Officer of the Company, under the terms of this Agreement.  Executive will report directly to the Company’s Chief Executive Officer (“CEO”).  Executive shall render such business and professional services in the performance of Executive’s duties, consistent with Executive’s position within the Company, as will be reasonably assigned to Executive by the Company’s Board of Directors (“Board”) or the CEO.  Executive’s principal place of employment will be San Jose, California.
1.2.2    Obligations.  During the Term, Executive will perform Executive’s duties faithfully and to the best of Executive’s ability and will devote Executive’s full business efforts and time to the business and affairs of the Company.  During the Term, Executive agrees not to actively engage in any other employment, occupation or 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 1 of 34

consulting activity for any direct or indirect remuneration without the prior written approval of the Board.  Executive may serve on the boards of directors of other companies, with the prior written approval of the Board, and engage in religious, charitable or other community activities as long as such services and activities are disclosed to the Board in writing in advance and do not materially interfere with Executive’s performance of Executive’s duties to the Company as provided in this Agreement.

2.    COMPENSATION AND RELATED MATTERS.
2.1    Base Salary.  During the Term, Executive’s initial annual base salary shall be $304,000.  Executive’s base salary shall be reassessed and determined periodically by the Board or the Company’s Compensation Committee (the “Committee”), as appropriate, in its sole discretion.  The base salary in effect at any given time is referred to herein as “Base Salary.” The Base Salary shall be payable in a manner that is consistent with the Company’s usual payroll practices for senior executives and will be subject to applicable tax and other required withholdings.
2.2    Incentive Compensation.  During the Term, Executive shall be eligible to receive cash incentive compensation as determined by the Board or the Committee, in its sole discretion, from time to time.  For the Company’s 2017 fiscal year, Executive’s target annual incentive compensation shall be 45% of Executive’s Base Salary, and will be awarded based on the objective and/or subjective criteria established and approved by the Board or the Committee, as applicable.  The Board or Committee shall have the sole discretion to determine whether Executive has earned any bonus and, if so, the amount of such bonus.
2.3    Equity.  The options and restricted stock units (“RSUs”) covering the Company’s common stock that previously were granted to Executive will continue to be subject to their existing terms and any additional terms set forth in this Agreement.  During the Term, Executive will be eligible to receive additional grants of stock-based awards covering shares of the Company’s common stock to be determined from time to time by and in the sole discretion of the Board or the Committee (including without limitation, the determination of the amount of such awards, number of shares, and/or value of such awards granted and the terms and conditions thereof, subject to any acceleration provisions contained herein).
2.4    Expenses.  During the Term, the Company will continue to reimburse Executive for reasonable travel, entertainment or other expenses incurred by Executive in the furtherance of or in connection with the performance of Executive’s duties, in accordance with the Company expense reimbursement policy applicable at the time the expenses are incurred.
2.5    Paid Time Off.  During the Term, Executive shall be entitled to receive paid time off in accordance with the Company’s policies, as in effect from time to time.
2.6    Other Benefits.  Aside from those benefits and compensation specified above, during the Term, Executive will be entitled to participate in such other benefit plans, programs, policies or other arrangements of the Company, if any, on similar terms and conditions as other similarly-situated senior executives of the Company to the extent that Executive is eligible to participate pursuant to the terms of such plans, programs, policies, or other arrangements.  The Company reserves the right to cancel or change such benefit plans, programs, policies and other arrangements it offers to its employees or executives at any time and for any reason.

3.    TERMINATION AND NOTICE OF TERMINATION.
During the Term, Executive’s employment may be terminated without any breach of this Agreement under the following circumstances:
3.1    Death.  Executive’s employment shall terminate upon Executive’s death.

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 2 of 34

3.2    Disability.  The Company may terminate Executive’s employment if Executive becomes Disabled (as defined below).  Nothing in this Section 3.2 shall be construed to waive Executive’s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the Americans with Disabilities Act, 42 U.S.C. §12101 et seq.
3.3    Termination by Company for Cause.  The Company may terminate Executive’s employment at any time for Cause (as defined below) by a vote of the Board at a meeting of the Board called and held for such purpose so long as Executive has reasonable notice of such meeting and is allowed to be represented by counsel at such meeting.
3.4    Termination Without Cause.  The Company may terminate Executive’s employment with the Company at any time without Cause.  Any termination by the Company of Executive’s employment under this Agreement that does not constitute a termination for Cause under Section 3.3 and does not result from Executive’s death or Executive becoming Disabled under Sections 3.1 or 3.2 shall be deemed a termination without Cause.
3.5    Termination by Executive.  Executive may terminate Executive’s employment with the Company at any time for any reason, including but not limited to Good Reason (as defined below).
3.6    Notice of Termination.  Except for termination as specified in Section 3.1 or 3.3, any termination of Executive’s employment by the Company or any such termination by Executive shall be communicated by written Notice of Termination to the other Party hereto.  For purposes of this Agreement, a “Notice of Termination” shall mean a notice that indicates the specific termination provision in this Agreement relied upon.  In the event that Executive delivers a Notice of Termination to the Company, the Company may unilaterally accelerate the date of termination of Executive’s employment and such acceleration shall not result in a termination by the Company for purposes of this Agreement.

4.    ACCRUED BENEFITS UPON TERMINATION.
If Executive’s employment with the Company is terminated for any reason (including any of the reasons set forth in Section 3), the Company shall pay or provide to Executive (or to Executive’s authorized representative or estate) (i) any Base Salary earned through the date of termination of Executive’s employment with the Company (the “Date of Termination”), unpaid expense reimbursements (subject to, and in accordance with, Section 2.4 of this Agreement) and accrued but unused vacation; and (ii) any vested benefits Executive may have under any employee benefit plan of the Company through the Date of Termination, which vested benefits shall be paid and/or provided in accordance with the terms of such employee benefit plans (collectively, the “Accrued Benefits”).

5.    TERMINATION BY THE COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON OTHER THAN DURING THE CHANGE IN CONTROL PERIOD.
During the Term, if Executive’s employment is terminated by the Company without Cause as provided in Section 3.4, or Executive terminates Executive’s employment with the Company for Good Reason as provided in Section 3.5, then subject to Executive signing the Company’s standard separation agreement and release in substantially the form attached hereto as Exhibit A (the “Release”), and the Release becoming effective and irrevocable within 60 days after the Date of Termination (such deadline date, the “Release Deadline Date”), Executive will receive the following under Sections 5.1 through 5.2:
5.1    Cash Severance.  A lump sum cash amount equal to 100% of the sum of (a) Executive’s Base Salary; and
5.2    COBRA Severance.  A lump sum cash amount equal to the product of 12 months, multiplied by the monthly premium pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), that Executive would be required to pay to continue the group health coverage in effect on the Date 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 3 of 34

of Termination for Executive and any of Executive’s eligible dependents (which amount will be based on the premium for the first month of COBRA coverage).
5.3    Subject to Section 10, the amounts payable under this Section 5, less applicable deductions and withholding, shall be paid out in a single lump sum within 60 days following the Date of Termination, provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, the amounts payable under this Section 5 shall be paid in the second calendar year.

6.    CHANGE IN CONTROL.
The provisions of this Section 6 and the enhanced compensation and benefits under Section 7 are intended to assure and encourage in advance Executive’s continued attention and dedication to Executive’s assigned duties and Executive’s objectivity during the pendency and after the occurrence of a Change in Control of the Company.  These provisions shall apply in lieu of, and expressly supersede, the provisions of Section 5 regarding severance pay and benefits upon a termination of employment, if such termination of employment occurs during the Change in Control Period (as defined below).  These provisions shall terminate and be of no further force or effect beginning 12 months after a Change in Control.

7.    TERMINATION BY THE COMPANY WITHOUT CAUSE OR BY EXECUTIVE FOR GOOD REASON DURING THE CHANGE IN CONTROL PERIOD.
During the Term, if during the Change in Control Period, Executive’s employment is terminated by the Company without Cause or Executive terminates Executive’s employment for Good Reason, then subject to Executive signing and not revoking the Release and the Release becoming effective and irrevocable by the Release Deadline Date, Executive will receive the following under Sections 7.1 through 7.3:
7.1    Cash Severance.  A lump sum cash amount equal to 100% of the sum of (a) Executive’s then-current Base Salary (or Executive’s Base Salary in effect immediately prior to the Change in Control, if higher) plus (b) Executive’s target incentive compensation, as determined under Section 2.2; and
7.2    Vesting Acceleration.  100% of the unvested portion of all Equity Awards shall immediately accelerate and become fully exercisable or non-forfeitable as of the Date of Termination.  To the extent that any Equity Award was eligible to vest in full or in part based on performance, the performance component shall be deemed to have been achieved at target.  If any Equity Award will not continue through assumption or substitution after the Change in Control, such award will be fully vested immediately prior to the Change in Control; and
7.3    COBRA Severance.  A lump sum cash amount equal to the product of 12 months, multiplied by the monthly premium pursuant to COBRA, that Executive would be required to pay to continue the group health coverage in effect on the Date of Termination (which amount will be based on the premium for the first month of COBRA coverage).
7.4    Subject to Section 10, the amounts payable under this Section 7, less applicable deductions and withholding, shall be paid out in a single lump sum within 60 days following the Date of Termination, provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, the amounts payable under this Section 7 shall be paid in the second calendar year.

8.    SECTION 280G LIMITATION ON PAYMENTS.
8.1    If any compensation, payment or distribution by the Company to or for the benefit of Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”) and the applicable regulations thereunder (the “280G Amounts”), (a) constitutes a “parachute payment” within the meaning 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 4 of 34

of Code Section 280G and (b) but for this Section 8, would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the 280G Amounts will be either (x) delivered in full; or (y) delivered as to such lesser extent that would result in no portion of the 280G Amounts being subject to the Excise Tax; whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by the Covered Employee on an after-tax basis, of the greatest amount of 280G Amounts, notwithstanding that all or some portion of the 280G Amounts may be taxable under Section 4999 of the Code.
8.2    If a reduction of 280G Amounts is made in accordance with this Section 8, the reduction will occur, with respect to the 280G Amounts considered parachute payments within the meaning of Section 280G of the Code, in the following order: (a) cash payments not subject to Section 409A (as defined below) in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first cash payment to be reduced); (b) cash payments subject to Section 409A in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first cash payment to be reduced); (c) equity award payments and acceleration in the reverse order of date of grant of the equity awards (that is, the vesting of the most recently granted equity awards will be cancelled first); and (d) non-cash forms of benefits in reverse chronological order (that is, the benefit owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first benefit to be reduced). In no event will Executive have any discretion with respect to the ordering of payment reductions.
8.3    Unless the Company and the Covered Employee otherwise agree in writing, any determination required under this Section 8 shall be made in writing by a nationally recognized accounting or valuation firm selected by the Company (the “Accounting Firm”).  For purposes of determining whether any reduction under this Section 8 shall apply to any 280G Amounts, Executive shall be deemed to pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual taxation in the state and locality of Executive’s residence on the Date of Termination, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. For purposes of making the calculations required by this Section 8, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  Any determination by the Accounting Firm shall be conclusive and binding upon the Company and Executive for all purposes.  The Company and the Covered Employee will furnish to the Firm such information and documents as the Firm may reasonably request in order to make a determination under this Section 8.  The Company will bear the costs and make all payments for the Firm’s services in connection with any calculations contemplated by this Section 8.
8.4    If, notwithstanding any reduction described in this Section 8, the IRS determines that Executive is liable for the Excise Tax as a result of the receipt of the payment of benefits as described above, then Executive shall be obligated to pay back to the Company, within thirty (30) days after a final IRS determination or in the event that Executive challenges the final IRS determination, a final judicial determination, a portion of the payment equal to the “Repayment Amount.”  The “Repayment Amount” with respect to the payment of benefits shall be the smallest such amount, if any, as shall be required to be paid to the Company so that Executive’s net after-tax proceeds with respect to any payment of benefits (after taking into account the payment of the Excise Tax and all other applicable taxes imposed on such payment) shall be maximized.  The Repayment Amount with respect to the payment of benefits shall be zero if a Repayment Amount of more than zero would not result in Executive’s net after-tax proceeds with respect to the payment of such benefits being maximized.  If the Excise Tax is not eliminated pursuant to this paragraph, Executive shall pay the Excise Tax.
8.5    Notwithstanding any other provision of this Section 8, if (a) there is a reduction in the payment of benefits as described in this Section 8, (b) the IRS later determines that Executive is liable for the Excise Tax, the payment of which would result in the maximization of Executive’s net after-tax proceeds (calculated as if Executive’s benefits 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 5 of 34

had not previously been reduced), and (c) Executive pays the Excise Tax, then the Company shall pay to Executive those benefits which were reduced pursuant to this Section 8 contemporaneously or as soon as administratively possible after Executive pays the Excise Tax so that Executive’s net after-tax proceeds with respect to the payment of benefits is maximized.

9.    CERTAIN DEFINITIONS.
9.1    Cause.  For purposes of this Agreement, “Cause” shall mean:
(a)    a material act of dishonesty made by Executive in connection with Executive’s responsibilities as an employee;
(b)    Executive being convicted of, or Executive’s plea of nolo contendere to, a felony or any crime involving fraud or embezzlement;
(c)    Executive’s gross misconduct in connection with the performance of Executive’s duties;
(d)    Executive’s willful breach of any material obligations under any written agreement or covenant with the Company;
(e)    Executive’s failure to cooperate in good faith with a governmental or internal investigation of the Company or its directors, officers or employees, if the Company has requested Executive’s cooperation; or
(f)    Executive’s continued failure to perform Executive’s employment duties after Executive has received a written demand of performance from the Company which specifically sets forth the factual basis for the Company’s belief that Executive has not substantially performed Executive’s duties.
Provided however that “Cause” will not be deemed to exist in the event of clauses (e) and (f) unless Executive has been provided with (x) thirty (30) days written notice by the Board of the act or omission constituting “Cause” and (y) thirty (30) days opportunity to cure such act or omission, if capable of cure.
9.2    Change in Control.  For purposes of this Agreement, “Change in Control” shall mean any of the following:
(a)    A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the Company; provided, that for this Section 9.2(a), the acquisition of additional stock by any one Person, who prior to such acquisition is considered to own more than 50% of the total voting power of the stock of the Company will not be considered a Change in Control. Further, if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company’s voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of 50% or more of the total voting power of the stock of the Company, such event shall not be considered a Change in Control under this Section 9.2(a).  For this purpose, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or
(b)    A change in the effective control of the Company which occurs on the date a majority of members of the Board is replaced during any 12-month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the appointment or election.  For this Section 9.2(b), if any Person is in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control; or

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 6 of 34

(c)    A change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the 12-month period ending on the date of the most recent acquisition by such Person or Persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions; provided, that for this Section 9.2(c), the following will not constitute a change in the ownership of a substantial portion of the Company’s assets:
(i)    a transfer to an entity controlled by the Company’s stockholders immediately after the transfer, or
(ii)    a transfer of assets by the Company to:
(A)    a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company’s stock,
(B)    an entity, 50% or more of the total value or voting power of which is owned, directly or indirectly, by the Company,
(C)    a Person, that owns, directly or indirectly, 50% or more of the total value or voting power of all the outstanding stock of the Company, or
(D)    an entity, at least 50% of the total value or voting power of which is owned, directly or indirectly, by a Person described in subsections 9.2(c)(ii)(A) to 9.2(c)(ii)(C).
For this definition, gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.  For this definition, persons will be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.
A transaction will not be a Change in Control: (x) unless the transaction qualifies as a change in control event within the meaning of Section 409A; or (y) if its primary purpose is to (1) change the state of the Company’s incorporation, or (2) create a holding company owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.
9.3    Change in Control Period.  For purposes of this Agreement, “Change in Control Period” shall mean the period beginning on the date three months prior to the first Change in Control to occur on or after the Effective Date and ending on the date 12 months after such Change in Control.
9.4    Disabled.  For purposes of this Agreement, “Disabled” shall mean Executive being unable to perform the essential functions of Executive’s then existing position or positions under this Agreement with or without reasonable accommodation.  If any question shall arise as to whether during any period Executive is Disabled so as to be unable to perform the essential functions of Executive’s then existing position or positions with or without reasonable accommodation, Executive may, and at the request of the Company shall, in accordance with all applicable laws, submit to the Company a certification in reasonable detail by a medical provider as to whether Executive is so Disabled.  If such question shall arise and Executive shall fail to submit such certification, the Company’s determination of such issue shall be binding on Executive.
9.5    Good Reason.  For purposes of this Agreement, “Good Reason” shall mean the occurrence of any of the following events, without Executive’s written consent:
(a)    a material reduction of Executive’s Base Salary;
(b)    a material reduction of Executive’s target cash incentive opportunity as set forth herein or as increased during the course of Executive’s employment with the Company;

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 7 of 34

(c)    a material reduction in Executive’s duties, authority, reporting relationship or responsibilities;
(d)    a requirement that Executive relocate to a location more than fifty (50) miles from Executive’s then-current office location;
(e)    a material violation by the Company of a material term of any employment, severance or change of control agreement between Executive and the Company; or
(f)    a failure by any successor entity to the Company to assume this Agreement.
A termination by Executive for Good Reason will not be deemed to have occurred unless Executive gives the Company written notice of the condition within ninety (90) days after the condition comes into existence, the Company fails to remedy the condition within thirty (30) days after receiving the written notice (the “Cure Period”), and Executive terminates Executive’s employment with the Company within ninety (90) days following the expiration of the Cure Period.
9.6    Section 409A.  For purposes of this Agreement, “Section 409A” shall mean Section 409A of the Code and the regulations and any guidance promulgated thereunder and any state law equivalent thereof.

10.    SECTION 409A.
10.1    Notwithstanding anything to the contrary in this Agreement, no separation payments or benefits to be provided to Executive, if any, pursuant to this Agreement that, when considered together with any other separation payments or benefits, are considered deferred compensation under Section 409A (together, the “Deferred Payments”) will be provided until Executive has a “separation from service” within the meaning of Section 409A.  Similarly, no separation payments or benefits to be provided to Executive, if any, pursuant to this Agreement that otherwise would be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9) will be payable until Executive has a “separation from service” within the meaning of Section 409A.  Further, provided that the Release becomes effective and irrevocable in accordance with Sections 5 or 7, as applicable, in the event that the termination of Executive’s employment occurs at a time during the calendar year when the Release could become effective in the calendar year immediately following the calendar year in which the termination of Executive’s employment occurs (regardless of which calendar year the Release actually becomes effective and irrevocable), then any severance payments that would be considered Deferred Payments that otherwise are payable between the date of termination of Executive’s employment and the Release Deadline Date will be paid, or in the case of installments, will commence, on the Release Deadline Date, and any remaining or other severance payments will be paid in accordance with their payment schedule as provided in this Agreement.
10.2    It is intended that none of the severance payments under this Agreement will constitute Deferred Payments but rather will be exempt from Section 409A as payments that would fall within the “short-term deferral period” as described in Section 10.4 below or resulting from an involuntary separation from service as described in Section 10.5 below.  In no event will Executive have discretion to determine the taxable year of payment of any Deferred Payment.
10.3    Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s separation from service (other than due to death), then the Deferred Payments, if any, that are payable within the first six months following Executive’s separation from service, will become payable on the first payroll date that occurs on or after the date six months and one day following the date of Executive’s separation from service. All subsequent Deferred Payments, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit.  Notwithstanding anything herein to the contrary, in the event of Executive’s death following Executive’s separation from service, but before the 6 month anniversary of the separation from service, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive’s death and all 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 8 of 34

other Deferred Payments will be payable in accordance with the payment schedule applicable to each payment or benefit.  Each payment and benefit payable under this Agreement is intended to constitute a separate payment under Section 1.409A-2(b)(2) of the Treasury Regulations.
10.4    Any amount paid under this Agreement that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Payments for purposes of clause (a) above.
10.5    Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that does not exceed the Section 409A Limit will not constitute Deferred Payments for purposes of Section 10.1 above.
10.6    The foregoing provisions are intended to comply with or be exempt from the requirements of Section 409A so that none of the separation payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to so comply or be exempt.  For purposes of this Agreement, to the extent required to be exempt from or comply with Section 409A with respect to any separation payments or benefits, references to Executive’s “termination of employment,” “Date of Termination,” or other similar phrases will be references to Executive’s “separation from service” within the meaning of Section 409A.  The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition before actual payment to Executive under Section 409A.  In no event will the Company reimburse Executive for any taxes imposed or other costs incurred as result of Section 409A.

11.    Confidential Information.  Concurrently with the execution of this Agreement, Executive agrees to enter into the At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement by and between Executive and the Company attached hereto as Exhibit B (the “Confidentiality Agreement”).

12.    Miscellaneous.
12.1    Consent to Jurisdiction.  To the extent that any court action is permitted consistent with this Agreement and the Confidentiality Agreement, the Parties hereby consent to the jurisdiction of the Superior Court of the State of California and the United States District Court for the District of Northern California.  Accordingly, with respect to any such court action, each Party (a) submits to the personal jurisdiction of such courts; (b) consents to service of process; and (c) waives any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process.
12.2    Integration.  This Agreement and the Confidentiality Agreement constitute the entire agreement between the Parties with respect to the subject matter hereof.  This Agreement supersedes and terminates all prior agreements between the Parties concerning such subject matter, including, for the avoidance of doubt, the Prior Agreement.
12.3    Withholding.  All payments made by the Company to Executive under this Agreement shall be net of any tax or other amounts required to be withheld by the Company under applicable law.
12.4    Successor to Executive.  This Agreement shall inure to the benefit of and be enforceable by Executive’s personal representatives, executors, administrators, heirs, distributees, devisees and legatees.  In the event of Executive’s death after the termination of Executive’s employment but prior to the completion by the Company of all payments due Executive under this Agreement, the Company shall continue such payments to Executive’s beneficiary designated in writing to the Company prior to Executive’s death (or to Executive’s estate, if Executive fails to make such designation).

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 9 of 34

12.5    Successor to Company.  The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Company expressly to assume and agree to perform this Agreement to the same extent that the Company would be required to perform it if no succession had taken place.  Failure of the Company to obtain an assumption of this Agreement at or prior to the effectiveness of any succession shall be a material breach of this Agreement.
12.6    Enforceability.  If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.
12.7    Survival.  The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of Executive’s employment to the extent necessary to effectuate the terms contained herein.
12.8    Waiver.  No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving Party.  The failure of any Party to require the performance of any term or obligation of this Agreement, or the waiver by any Party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.
12.9    Notices.  Any notices, requests, demands and other communications provided for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to Executive at the last address Executive has filed in writing with the Company or, in the case of the Company, at its main offices, attention of the Corporate Secretary.
12.10    Amendment.  This Agreement may be amended or modified only by a written instrument signed by Executive and by a duly authorized officer of the Company.
12.11    Governing Law.  This Agreement shall be construed under and be governed in all respects by the laws of the State of California, without giving effect to the conflict of laws principles of such State.  With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by the United States Court of Appeals for the Ninth Circuit.
12.12    Counterparts.  This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document.
12.13    Headings.  All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.
* * *
[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 10 of 34

Each Party is signing this Agreement on the date opposite its, his or her signature.
	
			
	 
	 
	FORESCOUT TECHNOLOGIES, INC. 

	7/8/2017 | 06:49 PDT
	 
	/s/ Michael DeCesare

	Date
	 
	Michael DeCesare

	 
	 
	President and Chief Executive Officer

	 
	 
	 

	 
	 
	DARREN J. MILLIKEN

	 
	 
	 

	7/8/2017 | 06:49 PDT
	 
	/s/ Darren J. Milliken

	Date
	 
	Darren J. Milliken

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 11 of 34

EXHIBIT A
FORM OF SEPARATION AGREEMENT AND RELEASE 
1(The Company may update this Exhibit prior to its use to reflect changes in law or circumstances)
This Separation Agreement and Release (“Separation Agreement”) is made by and between [CLICK AND TYPE NAME] (“Employee”) and ForeScout Technologies, Inc. (the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
RECITALS
WHEREAS, Employee was employed by the Company;
WHEREAS, Employee signed an Employment Agreement with the Company on [Click And Type Date] (the “Offer Letter”);
WHEREAS, Employee signed an [At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement] with the Company on [Click And Type Date] (the “Confidentiality Agreement”);
WHEREAS, [Include description of all of Employee’s equity awards] the Company and Employee have entered into a Stock Option Agreement, dated [Date], granting Employee the option to purchase shares of the Company’s common stock subject to the terms and conditions of the Company’s [Equity plan name] and the Stock Option Agreement thereunder (collectively the “Stock Agreements”);
WHEREAS, the Company terminated Employee’s employment with the Company effective [Click And Type Date] (the “Termination Date”); and
WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Employee may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Employee’s employment with or separation from the Company.
NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Employee hereby agree as follows:
COVENANTS
1.Consideration.  In exchange for Employee signing and not revoking this Agreement, Employee will receive: [insert description of the severance executive gets based on the circumstances giving rise to the  termination, as set forth above] Employee acknowledges that without this Agreement, Employee is otherwise not entitled to the consideration listed in this section 1.
2.    Stock.  [Revise as appropriate to include Employee’s equity awards.] The Parties agree that for purposes of determining the number of shares of the Company’s common stock that Employee is entitled to purchase from the Company, pursuant to the exercise of outstanding options, Employee will be considered to have vested only up to the Termination Date.  Employee acknowledges that as of the Termination Date, Employee will have 

1 Note to Company: This form to be used in CA only, and is drafted assuming the departing employee is age 40+. If more than one employee is being terminated, a different release agreement most likely is needed for a federal age discrimination waiver. Note that the agreement should be revised if the employee has not been paid all wages or if the employee has filed any litigation or administrative charge, or if there are any other circumstances that could create higher risk for the Company (such as the employee having made complaints about the Company, is disabled, on leave, etc.).

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 12 of 34

vested in [Click And Type Number] options and no more.  The exercise of Employee’s vested options and shares shall continue to be governed by the terms and conditions of the Company’s Stock Agreements.
3.    Benefits.  Employee’s health insurance benefits shall cease on [Date], subject to Employee’s right to continue Employee’s health insurance under COBRA.  Employee’s participation in all benefits and incidents of employment, including, but not limited to, vesting in stock options, and the accrual of bonuses, vacation, and paid time off, ceased as of the Termination Date.
4.    Payment of Salary and Receipt of All Benefits.  Employee acknowledges and represents that, other than the consideration set forth in this Agreement, the Company has paid or provided all salary, wages, bonuses, accrued vacation/paid time off, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, vesting, and any and all other benefits and compensation due to Employee.
5.    Release of Claims.  Employee agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Employee by the Company and its current and former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, professional employer organization or co-employer, insurers, trustees, divisions, and subsidiaries, and predecessor and successor corporations and assigns, (collectively, the “Releasees”).  Employee, on Employee’s own behalf and on behalf of Employee’s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Employee may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement, including, without limitation:
a.    any and all claims relating to or arising from Employee’s employment relationship with the Company and the termination of that relationship;
b.    any and all claims relating to, or arising from, Employee’s right to purchase, or actual purchase of shares of stock of the Company, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;
c.    any and all claims for wrongful discharge of employment, termination in violation of public policy, discrimination, harassment, retaliation, breach of contract (both express and implied), breach of covenant of good faith and fair dealing (both express and implied), promissory estoppel, negligent or intentional infliction of emotional distress, fraud, negligent or intentional misrepresentation, negligent or intentional interference with contract or prospective economic advantage, unfair business practices, defamation, libel, slander, negligence, personal injury, assault, battery, invasion of privacy, false imprisonment, conversion, and disability benefits;
d.    any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Rehabilitation Act of 1973, the Americans with Disabilities Act of 1990, the Equal Pay Act, the Fair Labor Standards Act, the Fair Credit Reporting Act, the Age Discrimination in Employment Act of 1967, the Older Workers Benefit Protection Act, the Employee Retirement Income Security Act of 1974, the Worker Adjustment and Retraining Notification Act, the Family and Medical Leave Act, the Immigration Reform and Control Act, the California Family Rights Act, the California Labor Code, the California Workers’ Compensation Act, and the California Fair Employment and Housing Act;

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 13 of 34

e.    any and all claims for violation of the federal or any state constitution;
f.    any and all claims arising out of any other laws and regulations relating to employment or employment discrimination;
g.    any claim for any loss, cost, damage, or expense arising out of any dispute over the nonwithholding or other tax treatment of any of the proceeds received by Employee as a result of this Agreement; and
h.    any and all claims for attorneys’ fees and costs.
Employee agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released.  This release does not extend to any obligations incurred under this Agreement.  This release does not release claims that cannot be released as a matter of law, including, but not necessarily limited to, any Protected Activity (as defined below).  [Any and all disputed wage claims that are released herein shall be subject to binding arbitration in accordance with Section 18, except as required by applicable law.]  This release does not extend to any right Employee may have to unemployment compensation benefits.
6.    Acknowledgment of Waiver of Claims under ADEA.  Employee acknowledges that Employee is waiving and releasing any rights Employee may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary.  Employee agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement.  Employee acknowledges that the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled.  Employee further acknowledges that Employee has been advised by this writing that: (a) Employee should consult with an attorney prior to executing this Agreement; (b) Employee has twenty-one (21) days within which to consider this Agreement; (c) Employee has seven (7) days following Employee’s execution of this Agreement to revoke this Agreement; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Employee signs this Agreement and returns it to the Company in less than the 21-day period identified above, Employee hereby acknowledges that Employee has freely and voluntarily chosen to waive the time period allotted for considering this Agreement.  Employee acknowledges and understands that revocation must be accomplished by a written notification to the person executing this Agreement on the Company’s behalf that is received prior to the Effective Date.  The Parties agree that changes, whether material or immaterial, do not restart the running of the 21-day period.
7.    California Civil Code Section 1542.  Employee acknowledges that Employee has been advised to consult with legal counsel and is familiar with the provisions of California Civil Code Section 1542, a statute that otherwise prohibits the release of unknown claims, which provides as follows:
A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.
Employee, being aware of said code section, agrees to expressly waive any rights Employee may have thereunder, as well as under any other statute or common law principles of similar effect.
8.    No Pending or Future Lawsuits.  Employee represents that Employee has no lawsuits, claims, or actions pending in Employee’s name, or on behalf of any other person or entity, against the Company or any of 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 14 of 34

the other Releasees.  Employee also represents that Employee does not intend to bring any claims on Employee’s own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.
9.    Application for Employment.  Employee understands and agrees that, as a condition of this Agreement, Employee shall not be entitled to any employment with the Company, and Employee hereby waives any right, or alleged right, of employment or re-employment with the Company.  Employee further agrees not to apply for employment with the Company and not otherwise pursue an independent contractor or vendor relationship with the Company.
10.    Confidentiality.  Subject to Section 13 governing Protected Activity, Employee agrees to maintain in complete confidence the existence of this Agreement, the contents and terms of this Agreement, and the consideration for this Agreement (hereinafter collectively referred to as “Separation Information”).  Except as required by law, Employee may disclose Separation Information only to Employee’s immediate family members, the Court in any proceedings to enforce the terms of this Agreement, Employee’s attorney(s), and Employee’s accountant(s) and any professional tax advisor(s) to the extent that they need to know the Separation Information in order to provide advice on tax treatment or to prepare tax returns, and must prevent disclosure of any Separation Information to all other third parties.  Employee agrees that Employee will not publicize, directly or indirectly, any Separation Information.
11.    Trade Secrets and Confidential Information/Company Property.  Employee reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreement, specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information, and nonsolicitation of Company employees.  Employee’s signature below constitutes Employee’s certification under penalty of perjury that Employee has returned all documents and other items provided to Employee by the Company (with the exception of a copy of the Employee Handbook and personnel documents specifically relating to Employee), developed or obtained by Employee in connection with Employee’s employment with the Company, or otherwise belonging to the Company.
12.    No Cooperation.  Subject to section 13 governing Protected Activity, Employee agrees that Employee will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver in this Agreement.  Employee agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order.  If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Employee shall state no more than that Employee cannot provide counsel or assistance.
13.    Protected Activity Not Prohibited.  Employee understands that nothing in this Agreement shall in any way limit or prohibit Employee from engaging in any Protected Activity, including filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (“Government Agencies”). Employee understands that in connection with such Protected Activity, Employee is permitted to disclose documents or other information as permitted by law, without giving notice to, or receiving authorization from, the Company.  Notwithstanding the foregoing, Employee agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information under the Confidentiality Agreement to any parties other than the Government Agencies.  Employee further understands that “Protected Activity” does not include the disclosure of any Company attorney-client privileged communications or attorney work product.  Any 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 15 of 34

language in the Confidentiality Agreement regarding Employee’s right to engage in Protected Activity that conflicts with, or is contrary to, this section is superseded by this Agreement.  In addition, pursuant to the Defend Trade Secrets Act of 2016, Employee is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.  Finally, nothing in this Agreement constitutes a waiver of any rights Employee may have under the Sarbanes-Oxley Act.
14.    Nondisparagement.  Employee agrees to refrain from any disparagement, defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees.  Employee shall direct any inquiries by potential future employers to the Company’s human resources department.
15.    Breach.  In addition to the rights provided in the “Attorneys’ Fees” section below, Employee acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Employee challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreement shall entitle the Company immediately to recover and/or cease providing the consideration provided to Employee under this Agreement and to obtain damages, except as provided by law.
16.    No Admission of Liability.  Employee understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Employee.  No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Employee or to any third party.
17.    Costs.  The Parties shall each bear their own costs, attorneys’ fees, and other fees incurred in connection with the preparation of this Agreement.
18.    ARBITRATION.  EXCEPT AS PROHIBITED BY LAW, THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, EMPLOYEE’S EMPLOYMENT WITH THE COMPANY OR THE TERMS THEREOF, OR ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION IN SANTA CLARA COUNTY, BEFORE JUDICIAL ARBITRATION & MEDIATION SERVICES (“JAMS”), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (“JAMS RULES”).  THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES.  THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE, AND THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION.  THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD.  THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 16 of 34

EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES; PROVIDED, HOWEVER, THAT THE ARBITRATOR MAY AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW.  THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY.  NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE.  SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS SECTION CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.
19.    Tax Consequences.  The Company makes no representations or warranties with respect to the tax consequences of the payments and any other consideration provided to Employee or made on Employee’s behalf under the terms of this Agreement.  Employee agrees and understands that Employee is responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon.  Employee further agrees to indemnify and hold the Releasees harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Employee’s failure to pay or delayed payment of federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs.
20.    Section 409A.2  It is intended that this Agreement comply with, or be exempt from, Code Section 409A and the final regulations and official guidance thereunder (“Section 409A”) and any ambiguities herein will be interpreted to so comply and/or be exempt from Section 409A.  Each payment and benefit to be paid or provided under this Agreement is intended to constitute a series of separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.  The Company and Employee will work together in good faith to consider either (i) amendments to this Agreement; or (ii) revisions to this Agreement with respect to the payment of any awards, which are necessary or appropriate to avoid imposition of any additional tax or income recognition prior to the actual payment to Employee under Section 409A.  In no event will the Releasees reimburse Employee for any taxes imposed or other costs incurred as a result of Section 409A.
21.    Authority.  The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement.  Employee represents and warrants that Employee has the capacity to act on Employee’s own behalf and on behalf of all who might claim through Employee to bind them to the terms and conditions of this Agreement.  Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.
22.    Severability.  In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.
23.    Attorneys’ Fees.  Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and 

2 [Note: To be revised as appropriate based on the severance benefits to be provided and Employee’s circumstances at separation.]

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 17 of 34

expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action.
24.    Entire Agreement.  This Agreement represents the entire agreement and understanding between the Company and Employee concerning the subject matter of this Agreement and Employee’s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Employee’s relationship with the Company, with the exception of the Confidentiality Agreement and the Stock Agreements, except as otherwise modified or superseded herein.
25.    No Oral Modification.  This Agreement may only be amended in a writing signed by Employee and the Company’s Chief Executive Officer.
26.    Governing Law.  This Agreement shall be governed by the laws of the State of California, without regard for choice-of-law provisions.  Employee consents to personal and exclusive jurisdiction and venue in the State of California.
27.    Effective Date.  Employee understands that this Agreement shall be null and void if not executed by Employee within twenty-one (21) days.  Each Party has seven (7) days after that Party signs this Agreement to revoke it.  This Agreement will become effective on the eighth (8th) day after Employee signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”).
28.    Counterparts.  This Agreement may be executed in counterparts and each counterpart shall be deemed an original and all of which counterparts taken together shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.  The counterparts of this Agreement may be executed and delivered by facsimile, photo, email PDF, or other electronic transmission or signature.
29.    Voluntary Execution of Agreement.  Employee understands and agrees that Employee executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of Employee’s claims against the Company and any of the other Releasees.  Employee acknowledges that:
(a)    Employee has read this Agreement;
		
	(b)
	Employee has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Employee’s own choice or has elected not to retain legal counsel;

		
	(c)
	Employee understands the terms and consequences of this Agreement and of the releases it contains;

		
	(d)
	Employee is fully aware of the legal and binding effect of this Agreement; and

		
	(e)
	Employee has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.

[THE REMAINDER OF THIS PAGE IS INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS]

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 18 of 34

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.
	
					
	 
	 
	 
	[CLICK & TYPE EMPLOYEE NAME], an individual

	 
	 
	 
	 
	 

	Dated:
	DO NOT DATE
	 
	FORM OF AGREEMENT, DO NOT SIGN

	 
	 
	 
	[Click and Type Employee Name]

	 
	 
	 
	 
	 

	 
	 
	 
	FORESCOUT TECHNOLOGIES, INC.

	 
	 
	 
	 
	 

	Dated:
	DO NOT DATE
	 
	By
	FORM OF AGREEMENT, DO NOT SIGN

	 
	 
	 
	[Click and Type Officer Name]

	 
	 
	 
	[Click and Type Title]

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 19 of 34

EXHIBIT B
FORESCOUT TECHNOLOGIES, INC. 
AT-WILL EMPLOYMENT, CONFIDENTIAL INFORMATION, 
INVENTION ASSIGNMENT, AND ARBITRATION AGREEMENT
As a condition of my employment with ForeScout Technologies, Inc. (the “Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by Company, I agree to the following provisions of this At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (this “Agreement”):
1.AT-WILL EMPLOYMENT
I UNDERSTAND AND ACKNOWLEDGE THAT MY EMPLOYMENT WITH THE COMPANY IS FOR NO SPECIFIED TERM AND CONSTITUTES “AT-WILL” EMPLOYMENT.  I ALSO UNDERSTAND THAT ANY REPRESENTATION TO THE CONTRARY IS UNAUTHORIZED AND NOT VALID UNLESS IN WRITING AND SIGNED BY THE PRESIDENT OR CEO OF THE COMPANY.  ACCORDINGLY, I ACKNOWLEDGE THAT MY EMPLOYMENT RELATIONSHIP MAY BE TERMINATED AT ANY TIME, WITH OR WITHOUT GOOD CAUSE OR FOR ANY OR NO CAUSE, AT MY OPTION OR AT THE OPTION OF THE COMPANY, WITH OR WITHOUT NOTICE.  I FURTHER ACKNOWLEDGE THAT THE COMPANY MAY MODIFY JOB TITLES, SALARIES, AND BENEFITS FROM TIME TO TIME AS IT DEEMS NECESSARY.
2.    CONFIDENTIALITY
A.    Definition of Company Confidential Information.  I understand that “Company Confidential Information” means information (including any and all combinations of individual items of information) that the Company has or will develop, acquire, create, compile, discover or own, that has value in or to the Company’s business which is not generally known and which the Company wishes to maintain as confidential.  Company Confidential Information includes both information disclosed by the Company to me, and information developed or learned by me during the course of my employment with the Company.  Company Confidential Information also includes all information of which the unauthorized disclosure could be detrimental to the interests of the Company, whether or not such information is identified as Company Confidential Information.  By example, and without limitation, Company Confidential Information includes any and all non-public information that relates to the actual or anticipated business and/or products, research or development of the Company, or to the Company’s technical data, trade secrets, or know-how, including, but not limited to, research, product plans, or other information regarding the Company’s products or services and markets therefor, customer lists and customers (including, but not limited to, customers of the Company on which I called or with which I may become acquainted during the term of my employment), software, developments, inventions, discoveries, ideas, processes, formulas, technology, designs, drawings, engineering, hardware configuration information, marketing, finances, and other business information disclosed by the Company either directly or indirectly in writing, orally or by drawings or inspection of premises, parts, equipment, or other Company property. Notwithstanding the foregoing, Company Confidential Information shall not include any such information which I can establish (i) was publicly known or made generally available prior to the time of disclosure by the Company to me; (ii) becomes publicly known or made generally available after disclosure by the Company to me through no wrongful action or omission by me; or (iii) is in my rightful possession, without confidentiality obligations, at the time of disclosure by the Company as shown by my then-contemporaneous written records; provided that any combination of individual items of information shall not be deemed to be within any of the foregoing exceptions merely because one or more of the individual items are within such exception, unless the combination as a whole is within such exception. I understand that nothing in this Agreement is intended to limit employees’ rights to discuss the terms, wages, and working conditions of their employment, as protected by applicable law.

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 20 of 34

B.    Nonuse and Nondisclosure.  I agree that during and after my employment with the Company, I will hold in the strictest confidence and take all reasonable precautions to prevent any unauthorized use or disclosure of Company Confidential Information.  I will not (i) use Company Confidential Information for any purpose whatsoever other than for the benefit of the Company in the course of my employment, or (ii) disclose Company Confidential Information to any third party without the prior written authorization of the President, CEO, General Counsel, or the Board of Directors of the Company.  Prior to disclosure, when compelled by applicable law, I shall provide prior written notice to the President, CEO, and General Counsel of the Company (as applicable).  I agree that I obtain no title to any Company Confidential Information, and that the Company retains all Confidential Information as the sole property of the Company.  I understand that my unauthorized use or disclosure of Company Confidential Information during my employment may lead to disciplinary action, up to and including, immediate termination and legal action by the Company.  I understand that my obligations under this Section 2.B shall continue after termination of my employment and also that nothing in this Agreement prevents me from engaging in protected activity, as described in Section 14 below.
C.    Former Employer Confidential Information.  I agree that during my employment with the Company, I will not improperly use, disclose, or induce the Company to use any proprietary information or trade secrets of any former employer or other person or entity with which I have an obligation to keep such proprietary information or trade secrets in confidence.  I further agree that I will not bring onto the Company’s premises or transfer onto the Company’s technology systems any unpublished document, proprietary information, or trade secrets belonging to any such third party unless disclosure to, and use by, the Company has been consented to, in writing, by such third party and the Company.
D.    Third Party Information.  I recognize that the Company has received, and in the future may receive, from third parties (for example, customers, suppliers, licensors, licensees, partners, and collaborators) as well as its subsidiaries and affiliates (“Associated Third Parties”), information which the Company is required to maintain and treat as confidential or proprietary information of such Associated Third Parties (“Associated Third Party Confidential Information”), and I agree to use such Associated Third Party Confidential Information only as directed by the Company and to not use or disclose such Associated Third Party Confidential Information in a manner that would violate the Company’s obligations to such Associated Third Parties.  By way of example, Associated Third Party Confidential Information may include the habits or practices of Associated Third Parties, the technology of Associated Third Parties, requirements of Associated Third Parties, and information related to the business conducted between the Company and such Associated Third Parties.  I agree at all times during my employment with the Company and thereafter, that I owe the Company and its Associated Third Parties a duty to hold all such Associated Third Party Confidential Information in the strictest confidence, and not to use it or to disclose it to any person, firm, corporation, or other third party except as necessary in carrying out my work for the Company consistent with the Company’s agreement with such Associated Third Parties.  I further agree to comply with any and all Company policies and guidelines that may be adopted from time to time regarding Associated Third Parties and Associated Third Party Confidential Information.  I understand that my unauthorized use or disclosure of Associated Third Party Confidential Information or violation of any Company policies during my employment may lead to disciplinary action, up to and including, immediate termination and legal action by the Company.
3.    OWNERSHIP
A.    Assignment of Inventions.  As between the Company and myself, I agree that all right, title, and interest in and to any and all copyrightable material, notes, records, drawings, designs, logos, inventions, improvements, developments, discoveries, ideas and trade secrets conceived, discovered, authored, invented, developed or reduced to practice by me, solely or in collaboration with others, during the period of time I am in the employ of the Company (including during my off-duty hours), or with the use of Company’s equipment, supplies, facilities, or Company Confidential Information, and any copyrights, patents, trade secrets, mask work rights or 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 21 of 34

other intellectual property rights relating to the foregoing, except as provided in Section 3.G below (collectively, “Inventions”), are the sole property of the Company. I also agree to promptly make full written disclosure to the Company of any Inventions, and to deliver and assign and hereby irrevocably assign fully to the Company all of my right, title and interest in and to Inventions.  I agree that this assignment includes a present conveyance to the Company of ownership of Inventions that are not yet in existence.  I further acknowledge that all original works of authorship that are made by me (solely or jointly with others) within the scope of and during the period of my employment with the Company and that are protectable by copyright are “works made for hire,” as that term is defined in the United States Copyright Act.  I understand and agree that the decision whether or not to commercialize or market any Inventions is within the Company’s sole discretion and for the Company’s sole benefit, and that no royalty or other consideration will be due to me as a result of the Company’s efforts to commercialize or market any such Inventions.  I understand that any and all Inventions that I may work on with personnel of the Company or any of its affiliates constitute joint research between the Company or any of its affiliates, as applicable, for the purposes of 35 U.S.C. section 103(c)(2).
B.    Pre-Existing Materials.  I will inform the Company, in writing, before incorporating any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets and other proprietary information or intellectual property rights owned by me or in which I have an interest prior to, or separate from, my employment with the Company, including, without limitation, any such inventions that are subject to California Labor Code Section 2870 (attached hereto as Exhibit B) (“Prior Inventions”) into any Invention or otherwise utilizing any Prior Invention in the course of my employment with the Company; and the Company is hereby granted a nonexclusive, royalty-free, perpetual, irrevocable, transferable worldwide license (with the right to grant and authorize sublicenses) to make, have made, use, import, offer for sale, sell, reproduce, distribute, modify, adapt, prepare derivative works of, display, perform, and otherwise exploit such incorporated or utilized Prior Inventions, without restriction, including, without limitation, as part of, or in connection with, such Invention, and to practice any method related thereto. I will not incorporate any inventions, discoveries, ideas, original works of authorship, developments, improvements, trade secrets and other proprietary information or intellectual property rights owned by any third party into any Invention without the Company’s prior written permission.  I have attached hereto, as Exhibit A a list describing all Prior Inventions that relate to the Company’s current or anticipated business, products, or research and development or, if no such list is attached, I represent and warrant that there are no such Prior Inventions.  Furthermore, I represent and warrant that if any Prior Inventions are included on Exhibit A, they will not materially affect my ability to perform all obligations under this Agreement.
C.    Moral Rights.  Any assignment to the Company of Inventions includes all rights of attribution, paternity, integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral Rights”).  To the extent that Moral Rights cannot be assigned under applicable law, I hereby waive and agree not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent permitted under applicable law.
D.    Maintenance of Records.  I agree to keep and maintain adequate, current, accurate, and authentic written records of all Inventions made by me (solely or jointly with others) during the term of my employment with the Company.  The records will be in the form of notes, sketches, drawings, electronic files, reports, or any other format that may be specified by the Company.  As between the Company and myself, the records are and will be available to and remain the sole property of the Company at all times.
E.    Further Assurances.  I agree to assist the Company, or its designee, at the Company’s expense, in every proper way to secure the Company’s rights in the Inventions in any and all countries, including the disclosure to the Company of all pertinent information and data with respect thereto, the execution of all applications, specifications, oaths, assignments, and all other instruments that the Company shall deem proper or necessary in order to apply for, register, obtain, maintain, defend, and enforce such rights, and in order to deliver, 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 22 of 34

assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title, and interest in and to all Inventions, and testifying in a suit or other proceeding relating to such Inventions. I further agree that my obligations under this Section 3.E shall continue after the termination of this Agreement.
F.    Attorney-in-Fact.  I agree that, if the Company is unable because of my unavailability, mental or physical incapacity, or for any other reason to secure my signature with respect to any Inventions, including, without limitation, for the purpose of applying for or pursuing any application for any United States or foreign patents or mask work or copyright registrations covering the Inventions assigned to the Company in Section 3.A, then I hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney-in-fact, to act for and on my behalf to execute and file any papers and oaths, and to do all other lawfully permitted acts with respect to such Inventions to further the prosecution and issuance of patents, copyright and mask work registrations with the same legal force and effect as if executed by me. This power of attorney shall be deemed coupled with an interest, and shall be irrevocable.
G.    Exception to Assignments.  I UNDERSTAND THAT THE PROVISIONS OF THIS AGREEMENT REQUIRING ASSIGNMENT OF INVENTIONS (AS DEFINED UNDER SECTION 3.A ABOVE) TO THE COMPANY DO NOT APPLY TO ANY INVENTION THAT QUALIFIES FULLY UNDER THE PROVISIONS OF CALIFORNIA LABOR CODE SECTION 2870 (ATTACHED HERETO AS EXHIBIT B).  I WILL ADVISE THE COMPANY PROMPTLY IN WRITING OF ANY INVENTIONS THAT I BELIEVE MEET THE CRITERIA IN CALIFORNIA LABOR CODE SECTION 2870 AND ARE NOT OTHERWISE DISCLOSED ON EXHIBIT A TO PERMIT A DETERMINATION OF OWNERSHIP BY THE COMPANY.  ANY SUCH DISCLOSURE WILL BE RECEIVED IN CONFIDENCE.
4.    CONFLICTING OBLIGATIONS
A.    Current Obligations.  I agree that during the term of my employment with the Company, I will not engage in or undertake any other employment, occupation, consulting relationship, or commitment that is directly related to the business in which the Company is now involved or becomes involved or has plans to become involved, nor will I engage in any other activities that conflict with my obligations to the Company.
B.    Prior Relationships.  Without limiting Section 4.A, I represent and warrant that I have no other agreements, relationships, or commitments to any other person or entity that conflict with the provisions of this Agreement, my obligations to the Company under this Agreement, or my ability to become employed and perform the services for which I am being hired by the Company.  I further agree that if I have signed a confidentiality agreement or similar type of agreement with any former employer or other entity, I will comply with the terms of any such agreement to the extent that its terms are lawful under applicable law.  I represent and warrant that after undertaking a careful search (including searches of my computers, cell phones, electronic devices, and documents), I have returned all property and confidential information belonging to all prior employers (and/or other third parties I have performed services for in accordance with the terms of my applicable agreement).  Moreover, I agree to fully indemnify the Company, its directors, officers, agents, employees, investors, shareholders, administrators, affiliates, divisions, subsidiaries, predecessor and successor corporations, and assigns for all verdicts, judgments, settlements, and other losses incurred by any of them resulting from my breach of my obligations under any agreement with a third party to which I am a party or obligation to which I am bound, as well as any reasonable attorneys’ fees and costs if the plaintiff is the prevailing party in such an action, except as prohibited by law.
5.    RETURN OF COMPANY MATERIALS
A.    Definition of Electronic Media Equipment and Electronic Media Systems.  I understand that “Electronic Media Equipment” includes, but is not limited to, computers, external storage devices, thumb drives, mobile devices (including, but not limited to, smart phones, tablets, and e-readers), telephone equipment, and other electronic media devices.  I understand that “Electronic Media Systems” includes, but is not limited to, 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 23 of 34

computer servers, messaging and email systems or accounts, applications for computers or mobile devices, and web-based services (including cloud-based information storage accounts).
B.    Return of Company Property.  I understand that anything that I created or worked on for the Company while working for the Company belongs solely to the Company and that I cannot remove, retain, or use such information without the Company’s express written permission.  Accordingly, upon separation from employment with the Company or upon the Company’s request at any other time, I will immediately deliver to the Company, and will not keep in my possession, recreate, or deliver to anyone else, any and all Company property, including, but not limited to, Company Confidential Information, Associated Third Party Confidential Information, all Company equipment including all Company Electronic Media Equipment, all tangible embodiments of the Inventions, all electronically stored information and passwords to access such information, Company credit cards, records, data, notes, notebooks, reports, files, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, photographs, charts, any other documents and property, and reproductions of any of the foregoing items including, without limitation, those records maintained pursuant to Section 3.D. Notwithstanding the foregoing, I understand that I am allowed to keep a copy of the Company’s employee handbook and personnel records relating to my employment.
C.    Return of Company Information on Company Electronic Media Equipment.  In connection with my obligation to return information to the Company, I agree that I will not copy, delete, or alter any information, including personal information voluntarily created or stored, contained in Company Electronic Media Equipment before I return the information to the Company.
D.    Return of Company Information on Personal Electronic Media Equipment.  In addition, if I have used any personal Electronic Media Equipment or personal Electronic Media Systems to create, receive, store, review, prepare or transmit any Company information, including, but not limited to, Company Confidential Information, I agree to make a prompt and reasonable search for such information in good faith, including reviewing any personal Electronic Media Equipment or personal Electronic Media Systems to locate such information and, if I locate such information, I agree to notify the Company of that fact and then provide the Company with a computer-useable copy of all such Company information from those equipment and systems. I agree to cooperate reasonably with the Company to verify that the necessary copying is completed (including upon request providing a sworn declaration confirming the return of property and deletion of information), and, upon confirmation of compliance by the Company, I agree to delete and expunge all Company information.
E.    No Expectation of Privacy in Company Property.  I understand that I have no expectation of privacy in Company property, and I agree that any Company property is subject to inspection by Company personnel at any time with or without further notice.  As to any personal Electronic Media Equipment or personal Electronic Media Systems that I have used for Company purposes, I agree that the Company, at its sole discretion, may have reasonable access, as determined by the Company in good faith, to such personal Electronic Media Equipment or personal Electronic Media Systems to review, retrieve, destroy, or ensure the permanent deletion of Company information from such equipment or systems or to take such other actions necessary to protect the Company or Company property, as determined by the Company reasonably and in good faith. I also consent to an exit interview and an audit to confirm my compliance with this Section 5, and I will certify in writing that I have complied with the requirements of this Section 5.
6.    TERMINATION CERTIFICATION
Upon separation from employment with the Company, I agree to immediately sign and deliver to the Company the “Termination Certification” attached hereto as Exhibit C.

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 24 of 34

7.    NOTIFICATION OF NEW EMPLOYER
In the event that I leave the employ of the Company, I hereby grant consent to notification by the Company to my new employer about my obligations under this Agreement.  I also agree to keep the Company advised of my home and business address for a period of three (3) years after termination of my employment with the Company, so that the Company can contact me regarding my continuing obligations provided by this Agreement.
8.    SOLICITATION OF EMPLOYEES
To the fullest extent permitted under applicable law, I agree that during my employment, and for a period of twelve (12) months immediately following the termination of my relationship with the Company for any reason, whether voluntary or involuntary, with or without cause, I will not directly or indirectly solicit any of the Company’s employees to leave their employment at the Company.  I agree that nothing in this Section 8 shall affect my continuing obligations under this Agreement during and after this twelve (12) month period, including, without limitation, my obligations under Section 2.
9.    CONFLICT OF INTEREST GUIDELINES
I agree to diligently adhere to all policies of the Company, including the Company’s insider trading policies and the Company’s Conflict of Interest Guidelines.  A copy of the Company’s current Conflict of Interest Guidelines is attached as Exhibit D hereto, but I understand that these Conflict of Interest Guidelines may be revised from time to time during my employment.
10.    REPRESENTATIONS
Without limiting my obligations under Section 3.E above, I agree to execute any proper oath or verify any proper document required to carry out the terms of this Agreement.  I represent and warrant that my performance of all the terms of this Agreement will not breach any agreement to keep in confidence information acquired by me in confidence or in trust prior to my employment by the Company.  I hereby represent and warrant that I have not entered into, and I will not enter into, any oral or written agreement in conflict herewith.
11.    AUDIT
I acknowledge that I have no reasonable expectation of privacy in any Company Electronic Media Equipment or Company Electronic Media System.  All information, data, and messages created, received, sent, or stored in Company Electronic Media Equipment or Company Electronic Media Systems are, at all times, the property of the Company.  As such, the Company has the right to audit and search all such items and systems, without further notice to me, to ensure that the Company is licensed to use the software on the Company’s devices in compliance with the Company’s software licensing policies, to ensure compliance with the Company’s policies, and for any other business-related purposes in the Company’s sole discretion.  I understand that I am not permitted to add any unlicensed, unauthorized, or non-compliant applications to the Company’s technology systems, including, without limitation, open source or free software not authorized by the Company, and that I shall refrain from copying unlicensed software onto the Company’s technology systems or using non-licensed software or websites.  I understand that it is my responsibility to comply with the Company’s policies governing use of the Company’s documents and the internet, email, telephone, and technology systems to which I will have access in connection with my employment.  In addition, as to any personal Electronic Media Equipment or personal Electronic Systems or other personal property that I have used for Company purposes, I agree that the Company may have reasonable access to such personal Electronic Media Equipment or personal Electronic Media Systems or other personal property to review, retrieve, destroy, or ensure the permanent deletion of Company information from such equipment or systems or property or take such other actions that are needed to protect the Company or Company property, as determined by the Company reasonably and in good faith.

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 25 of 34

I am aware that the Company has or may acquire software and systems that are capable of monitoring and recording all Company network traffic to and from any Company Electronic Media Equipment or Company Electronic Media Systems.  The Company reserves the right to access, review, copy, and delete any of the information, data, or messages accessed through Company Electronic Media Equipment or Electronic Media Systems, with or without notice to me and/or in my absence.  This includes, but is not limited to, all e-mail messages sent or received, all website visits, all chat sessions, all news group activity (including groups visited, messages read, and postings by me), and all file transfers into and out of the Company’s internal networks.  The Company further reserves the right to retrieve previously deleted messages from e-mail or voicemail and monitor usage of the Internet, including websites visited and any information I have downloaded.  In addition, the Company may review Internet and technology systems activity and analyze usage patterns, and may choose to publicize this data to assure that technology systems are devoted to legitimate business purposes.
12.    ARBITRATION AND EQUITABLE RELIEF
A.    Arbitration.  IN CONSIDERATION OF MY EMPLOYMENT WITH THE COMPANY, ITS PROMISE TO ARBITRATE ALL EMPLOYMENT-RELATED DISPUTES WITH ME, AND MY RECEIPT OF THE COMPENSATION, PAY RAISES, AND OTHER BENEFITS PAID TO ME BY THE COMPANY, AT PRESENT AND IN THE FUTURE, I AGREE THAT ANY AND ALL CONTROVERSIES, CLAIMS, OR DISPUTES THAT I MAY HAVE WITH ANYONE (INCLUDING THE COMPANY AND ANY EMPLOYEE, OFFICER, DIRECTOR, SHAREHOLDER, OR BENEFIT PLAN OF THE COMPANY, IN THEIR CAPACITY AS SUCH OR OTHERWISE), ARISING OUT OF, RELATING TO, OR RESULTING FROM MY EMPLOYMENT OR RELATIONSHIP WITH THE COMPANY OR THE TERMINATION OF MY EMPLOYMENT OR RELATIONSHIP WITH THE COMPANY, INCLUDING ANY BREACH OF THIS AGREEMENT, SHALL BE SUBJECT TO BINDING ARBITRATION UNDER THE FEDERAL ARBITRATION ACT AND PURSUANT TO THE ARBITRATION PROVISIONS SET FORTH IN CALIFORNIA CODE OF CIVIL PROCEDURE SECTIONS 1280 THROUGH 1294.2 (THE “CCP ACT”) AND CALIFORNIA LAW. I UNDERSTAND THAT I MAY BRING A PROCEEDING AS A PRIVATE ATTORNEY GENERAL, AS PERMITTED BY LAW.  THE FEDERAL ARBITRATION ACT GOVERNS THIS AGREEMENT AND SHALL CONTINUE TO APPLY WITH FULL FORCE AND EFFECT, NOTWITHSTANDING THE APPLICATION OF PROCEDURAL RULES SET FORTH IN THE CCP ACT AND CALIFORNIA LAW.  I AGREE TO ARBITRATE ANY AND ALL COMMON LAW AND/OR STATUTORY CLAIMS UNDER LOCAL, STATE, OR FEDERAL LAW, INCLUDING, BUT NOT LIMITED TO,  CLAIMS UNDER TITLE VII OF THE CIVIL RIGHTS ACT OF 1964, THE AMERICANS WITH DISABILITIES ACT OF 1990,  THE AGE DISCRIMINATION IN EMPLOYMENT ACT OF 1967, THE OLDER WORKERS BENEFIT PROTECTION ACT, THE  WORKER ADJUSTMENT AND RETRAINING NOTIFICATION ACT, THE FAIR LABOR STANDARDS ACT, THE  CALIFORNIA FAIR EMPLOYMENT AND HOUSING ACT, THE FAMILY AND MEDICAL LEAVE ACT, THE CALIFORNIA FAMILY RIGHTS ACT, THE CALIFORNIA LABOR CODE, CLAIMS RELATING TO EMPLOYMENT STATUS,  CLASSIFICATION AND RELATIONSHIP WITH THE COMPANY, AND CLAIMS OF HARASSMENT, DISCRIMINATION,  WRONGFUL TERMINATION, AND BREACH OF CONTRACT, EXCEPT AS PROHIBITED BY LAW. I ALSO AGREE TO  ARBITRATE (EXCEPT AS PROHIBITED BY LAW) ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE  INTERPRETATION OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT DISPUTES ABOUT THE  ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT TO ARBITRATE OR ANY PORTION HEREOF.  WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT I AGREE TO ARBITRATE, I HEREBY EXPRESSLY AGREE  TO WAIVE, AND DO WAIVE, ANY RIGHT TO A TRIAL BY JURY.  I FURTHER UNDERSTAND THAT THIS AGREEMENT TO ARBITRATE ALSO APPLIES TO ANY DISPUTES THAT THE COMPANY MAY HAVE WITH ME.  I UNDERSTAND THAT NOTHING IN THIS AGREEMENT CONSTITUTES A WAIVER OF ANY RIGHTS I MAY HAVE UNDER APPLICABLE LAW, INCLUDING, BUT NOT NECESSARILY LIMITED TO, SECTION 7 OF THE NATIONAL LABOR RELATIONS ACT OR THE SARBANES-OXLEY ACT, INCLUDING ANY RIGHTS PROHIBITING 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 26 of 34

COMPULSORY ARBITRATION.  SIMILARLY, NOTHING IN THIS AGREEMENT PROHIBITS ME FROM ENGAGING IN PROTECTED ACTIVITY, AS SET FORTH BELOW.
B.    Procedure.  I AGREE THAT ANY ARBITRATION WILL BE ADMINISTERED BY JUDICIAL ARBITRATION & MEDIATION SERVICES, INC. (“JAMS”), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (THE “JAMS RULES”), WHICH ARE AVAILABLE AT http://www.jamsadr.com/rules-employment-arbitration/ AND FROM HUMAN RESOURCES.  I AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO DECIDE ANY MOTIONS BROUGHT BY ANY PARTY TO THE ARBITRATION, INCLUDING MOTIONS FOR SUMMARY JUDGMENT AND/OR ADJUDICATION, AND MOTIONS TO DISMISS AND DEMURRERS, APPLYING THE STANDARDS SET FORTH UNDER THE CALIFORNIA CODE OF CIVIL PROCEDURE.  I AGREE THAT THE ARBITRATOR SHALL ISSUE A WRITTEN DECISION ON THE MERITS.  I ALSO AGREE THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE LAW, AND THAT THE ARBITRATOR MAY AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW.  I AGREE THAT THE DECREE OR AWARD RENDERED BY THE ARBITRATOR MAY BE ENTERED AS A FINAL AND BINDING JUDGMENT IN ANY COURT HAVING JURISDICTION THEREOF.  I UNDERSTAND THAT THE COMPANY WILL PAY FOR ANY ADMINISTRATIVE OR HEARING FEES CHARGED BY THE ARBITRATOR OR JAMS EXCEPT THAT I SHALL PAY ANY FILING FEES ASSOCIATED WITH ANY ARBITRATION THAT I INITIATE, BUT ONLY SO MUCH OF THE FILING FEES AS I WOULD HAVE INSTEAD PAID HAD I FILED A COMPLAINT IN A COURT OF LAW.  I AGREE THAT THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH CALIFORNIA LAW, INCLUDING THE CALIFORNIA CODE OF CIVIL PROCEDURE AND THE CALIFORNIA EVIDENCE CODE, AND THAT THE ARBITRATOR SHALL APPLY SUBSTANTIVE AND PROCEDURAL CALIFORNIA LAW TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO RULES OF CONFLICT-OF-LAW.  TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH CALIFORNIA LAW, CALIFORNIA LAW SHALL TAKE PRECEDENCE.  I AGREE THAT ANY ARBITRATION UNDER THIS AGREEMENT SHALL BE CONDUCTED IN SANTA CLARA COUNTY, CALIFORNIA.
C.    Remedy.  EXCEPT AS PROVIDED BY THE CCP ACT AND THIS AGREEMENT, ARBITRATION SHALL BE THE SOLE, EXCLUSIVE, AND FINAL REMEDY FOR ANY DISPUTE BETWEEN ME AND THE COMPANY.  ACCORDINGLY, EXCEPT AS PROVIDED FOR BY THE CCP ACT OR THIS AGREEMENT, NEITHER I NOR THE COMPANY WILL BE PERMITTED TO PURSUE OR PARTICIPATE IN A COURT ACTION REGARDING CLAIMS THAT ARE SUBJECT TO ARBITRATION.
D.    Administrative Relief.  I UNDERSTAND THAT THIS AGREEMENT DOES NOT PROHIBIT ME FROM PURSUING AN ADMINISTRATIVE CLAIM WITH A LOCAL, STATE, OR FEDERAL ADMINISTRATIVE BODY OR GOVERNMENT AGENCY THAT IS AUTHORIZED TO ENFORCE OR ADMINISTER LAWS RELATED TO EMPLOYMENT, INCLUDING, BUT NOT LIMITED TO, THE DEPARTMENT OF FAIR EMPLOYMENT AND HOUSING, THE EQUAL EMPLOYMENT OPPORTUNITY COMMISSION, THE NATIONAL LABOR RELATIONS BOARD, THE SECURITIES AND EXCHANGE COMMISSION, OR THE WORKERS’ COMPENSATION BOARD.  THIS AGREEMENT DOES, HOWEVER, PRECLUDE ME FROM PURSUING A COURT ACTION REGARDING ANY SUCH CLAIM, EXCEPT AS PERMITTED BY LAW.
E.    Voluntary Nature of Agreement.  I ACKNOWLEDGE AND AGREE THAT I AM EXECUTING THIS AGREEMENT VOLUNTARILY AND WITHOUT ANY DURESS OR UNDUE INFLUENCE BY THE COMPANY OR ANYONE ELSE.  I FURTHER ACKNOWLEDGE AND AGREE THAT I HAVE CAREFULLY READ THIS AGREEMENT AND THAT I HAVE ASKED ANY QUESTIONS NEEDED FOR ME TO UNDERSTAND THE TERMS, CONSEQUENCES, AND BINDING EFFECT OF THIS 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 27 of 34

AGREEMENT AND FULLY UNDERSTAND IT, INCLUDING THAT I AM WAIVING MY RIGHT TO A JURY TRIAL.  FINALLY, I AGREE THAT I HAVE BEEN PROVIDED AN OPPORTUNITY TO SEEK THE ADVICE OF AN ATTORNEY OF MY CHOICE BEFORE SIGNING THIS AGREEMENT.
13.    MISCELLANEOUS
A.    Governing Law; Consent to Personal Jurisdiction.  This Agreement will be governed by the laws of the State of California without regard to California’s conflicts-of-law rules that may result in the application of the laws of any jurisdiction other than California.  To the extent that any lawsuit is permitted under this Agreement, I hereby expressly consent to the personal and exclusive jurisdiction and venue of the state and federal courts located in California for any lawsuit filed against me by the Company.
B.    Assignability.  This Agreement will be binding upon my heirs, executors, assigns, administrators, and other legal representatives, and will be for the benefit of the Company, its successors, and its assigns.  The Associated Third Parties are intended third-party beneficiaries to this Agreement with respect to my obligations in Section 2.D. Notwithstanding anything to the contrary herein, the Company may assign this Agreement and its rights and obligations under this Agreement to any successor to all, or substantially all, of the Company’s relevant assets, whether by merger, consolidation, reorganization, reincorporation, sale of assets or stock, or otherwise.  For avoidance of doubt, the Company’s successors and assigns are authorized to enforce the Company’s rights under this Agreement.
C.    Entire Agreement.  This Agreement, together with the Exhibits herein and any executed written offer letter between me and the Company, to the extent such materials are not in conflict with this Agreement, sets forth the entire agreement and understanding between the Company and me with respect to the subject matter herein and supersedes all prior written and oral agreements, discussions, or representations between us, including, but not limited to, any representations made during my interview(s) or relocation negotiations. I represent and warrant that I am not relying on any statement or representation not contained in this Agreement.  Any subsequent change or changes in my duties, salary, compensation, conditions or any other terms of my employment will not affect the validity or scope of this Agreement.
D.    Headings.  Headings are used in this Agreement for reference only and shall not be considered when interpreting this Agreement.
E.    Severability.  If a court or other body of competent jurisdiction finds, or the Parties mutually believe, any provision of this Agreement, or portion thereof, to be invalid or unenforceable, such provision will be enforced to the maximum extent permissible so as to effect the intent of the Parties, and the remainder of this Agreement will continue in full force and effect.
F.    Modification, Waiver.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, will be effective unless in a writing signed by the President or CEO of the Company and me.  Waiver by the Company of a breach of any provision of this Agreement will not operate as a waiver of any other or subsequent breach.
G.    Survivorship.  The rights and obligations of the Parties to this Agreement will survive termination of my employment with the Company.
H.    Applicability to Past Activities.  The Company and I acknowledge that I have been engaged to provide services by the Company for a period of time prior to the date of this Agreement starting on January 29, 2014 (the “Prior Engagement Period”).  Accordingly, I agree that if and to the extent that, during the Prior Engagement Period: (i) I received access to any information from or on behalf of Company that would have been Company Confidential Information if I received access to such information during the period of my employment with the Company under this Agreement; or (ii) I conceived, created, authored, invented, developed or reduced to 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 28 of 34

practice any item, including any intellectual property rights with respect thereto, that would have been an Invention if conceived, created, authored, invented, developed or reduced to practice during the period of my employment with the Company under this Agreement; then any such information shall be deemed Company Confidential Information hereunder and any such item shall be deemed an Invention hereunder, and this Agreement shall apply to such information or item as if conceived, created, authored, invented, developed or reduced to practice under this Agreement.
14.    PROTECTED ACTIVITY NOT PROHIBITED
I understand that nothing in this Agreement limits or prohibits me from filing a charge or complaint with, or otherwise communicating or cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (“Government Agencies”), including disclosing documents or other information as permitted by law, without giving notice to, or receiving authorization from, the Company. Notwithstanding, in making any such disclosures or communications, I agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company Confidential Information to any parties other than the Government Agencies.  I further understand that I am not permitted to disclose the Company’s attorney-client privileged communications or attorney work product.  In addition, I hereby acknowledge that the Company has provided me with notice in compliance with the Defend Trade Secrets Act of 2016 regarding immunity from liability for limited disclosures of trade secrets.  The full text of the notice is attached in Exhibit B.
	
				
	Date:
	4/27/2017 | 15:34 PDT
	 
	/s/ Darren J. Milliken

	 
	 
	 
	Signature

	 
	 
	 
	 

	 
	 
	 
	Darren J. Milliken

	 
	 
	 
	Name of Employee (typed or printed)

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 29 of 34

EXHIBIT A
LIST OF PRIOR INVENTIONS
AND ORIGINAL WORKS OF AUTHORSHIP
	
						
	Title
	 
	Date
	 
	Identifying Number or Brief
Description

	 
	 
	 
	 
	 

	x
	No inventions or improvements

	 
	Additional Sheets Attached

	
				
	Date:
	4/27/2017 | 15:34 PDT
	 
	/s/ Darren J. Milliken

	 
	 
	 
	Signature

	 
	 
	 
	 

	 
	 
	 
	Darren J. Milliken

	 
	 
	 
	Name of Employee (typed or printed)

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 30 of 34

EXHIBIT B
CALIFORNIA LABOR CODE SECTION 2870 
INVENTION ON OWN TIME - EXEMPTION FROM AGREEMENT
“(a)    Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either:
(1)    Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or
(2)    Result from any work performed by the employee for the employer.
(b)    To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.”
SECTION 7 OF THE DEFEND TRADE SECRETS ACT OF 2016
“ . . . An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that—(A) is made—(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. . . . An individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual—(A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except pursuant to court order.”

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 31 of 34

EXHIBIT C
FORM OF TERMINATION CERTIFICATION
This is to certify that I do not have in my possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, any other documents or property, or reproductions of any and all aforementioned items belonging to ForeScout Technologies, Inc. (the “Company”).  Notwithstanding the foregoing, I understand that I may keep a copy of the Company’s employee handbook and personnel records relating to me.
I further certify that I have complied with all the terms of the Company’s At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement (the “Agreement”) signed by me, including the reporting of any inventions and original works of authorship (as defined therein) conceived or made by me (solely or jointly with others), as covered by that Agreement.
I understand that pursuant to the Agreement, and subject to its protected activity exclusion, I am obligated to preserve, as confidential, all Company Confidential Information and Associated Third Party Confidential Information, including trade secrets, confidential knowledge, data, or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, databases, other original works of authorship, customer lists, business plans, financial information, or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants, or licensees.
I also acknowledge that under the Agreement, for twelve (12) months from this date, I may not directly or indirectly solicit any of the Company’s employees to leave their employment at the Company.  I understand that nothing in this paragraph affects my continuing obligations under the Agreement during and after this twelve (12) month period, including, without limitation, my obligations under Section 2 (Confidentiality) thereof.
After leaving the Company’s employment, I will be employed by ___________________________ in the position of ____________________________.
	
				
	Date:
	DO NOT DATE
	 
	FORM OF AGREEMENT, DO NOT SIGN

	 
	 
	 
	Signature

	 
	 
	 
	 

	 
	 
	 
	 

	 
	 
	 
	Name of Employee (typed or printed)

	 
	 
	 
	 

	Address for Notifications:
	 
	 

	 
	 
	 
	 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 32 of 34

EXHIBIT D
CONFLICT OF INTEREST GUIDELINES
It is the policy of ForeScout Technologies, Inc. to conduct its affairs in strict compliance with the letter and spirit of the law and to adhere to the highest principles of business ethics.  Accordingly, all officers, employees, and independent contractors must avoid activities that are in conflict, or give the appearance of being in conflict, with these principles and with the interests of the Company.  The following are potentially compromising situations that must be avoided:
1.Revealing confidential information to outsiders or misusing confidential information.  Unauthorized divulging of information is a violation of this policy whether or not for personal gain and whether or not harm to the Company is intended.  (The At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement elaborates on this principle and is a binding agreement.)
2.    Accepting or offering substantial gifts, excessive entertainment, favors, or payments that may be deemed to constitute undue influence or otherwise be improper or embarrassing to the Company.
3.    Participating in civic or professional organizations that might involve divulging confidential information of the Company.
4.    Initiating or approving personnel actions affecting reward or punishment of employees or applicants where there is a family relationship or is, or appears to be, a personal or social involvement.
5.    Initiating or approving any form of personal or social harassment of employees.
6.    Investing or holding outside directorship in suppliers, customers, or competing companies, including financial speculations, where such investment or directorship might influence in any manner a decision or course of action of the Company.
7.    Borrowing from or lending to employees, customers, or suppliers.
8.    Acquiring real estate of interest to the Company.
9.    Improperly using or disclosing to the Company any proprietary information or trade secrets of any other employer or other person or entity with whom obligations of confidentiality exist.
10.    Unlawfully discussing prices, costs, customers, sales, or markets with competing companies or their employees.
11.    Making any unlawful agreement with distributors with respect to prices.
12.    Improperly using or authorizing the use of any inventions that are the subject of patent claims of any other person or entity.
13.    Engaging in any conduct that is not in the best interest of the Company.
Each officer, employee, and independent contractor must take every necessary action to ensure compliance with these guidelines and to bring problem areas to the attention of higher management for review.  Violations of this conflict of interest policy may result in immediate termination of employment.
Nothing in these guidelines is intended to limit employees’ rights to discuss the terms, wages, and working conditions of their employment, as protected by applicable law, including any rights an employee may have under 

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 33 of 34

Section 7 of the National Labor Relations Act.  Also, nothing in these guidelines limits or prohibits employees from filing a charge or complaint with, or otherwise communicating or cooperating with or participating in any investigation or proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (“Government Agencies”), including disclosing documents or other information as permitted by law, without giving notice to, or receiving authorization from, the Company.  Notwithstanding, in making any such disclosures or communications, employees must take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company Confidential Information to any parties other than the Government Agencies.  Employees may not disclose the Company’s attorney-client privileged communications or attorney work product.

	
			
	ForeScout Employment Agreement
	ForeScout Confidential
	Page 34 of 34Exhibit

Exhibit 10.18

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT

THIS AGREEMENT (the “Agreement”) is made as of November 25, 2015, by and among ForeScout Technologies, Inc., a Delaware corporation (the “Company”), each Person listed in Schedule A attached hereto (together, the “Founders”), and each Person listed in Schedule B attached hereto (together, the “Investors”). Unless otherwise provided in this Agreement, capitalized terms used herein shall have the meanings set forth in Section 10 hereof.
Recitals
A.    The Company, the Founders and certain of the Investors have entered into that certain Amended and Restated Investors’ Rights Agreement dated September 8, 2014 (the “Prior Rights Agreement”).
B.    Certain of the Investors and the Company are parties to the Series G Preferred Stock Purchase Agreement dated November 24, 2015 (the “G Purchase Agreement”), pursuant to which the G Investors are purchasing Series G Preferred Stock of the Company.
C.    Whereas the parties desire to amend, restate and replace in its entirety, the Prior Rights Agreement, upon the initial closing of the sale of the Series G Preferred Stock pursuant to the G Purchase Agreement, with this Agreement.
D.    In consideration of the promises and mutual covenants set forth herein, the receipt and adequacy of which are hereby acknowledged, the parties hereto agree to amend and restate the Prior Rights Agreement in its entirety, which shall be of no further force or effect, as follows:
1.Registration Rights.
1.1    Right to Piggyback.
(a)    Right to Piggyback.  In connection with an IPO and at any time thereafter, but subject to the terms of any “lock-up agreement” entered into by a Holder with an underwriter for the IPO (unless waived by such underwriter), whenever the Company proposes to register any of its securities under the Securities Act (other than pursuant to a registration on Form S-4, Form S-8 or any successor form) and the registration form to be used may be used for the registration of Preferred Registrable Securities (a “Piggyback Registration”), the Company shall give prompt written notice to all Holders of its intention to effect such a registration.  Upon the written request of each Holder given within twenty (20) days after mailing of such notice by the Company in accordance in Section 11.7, the Company shall cause to be registered under the Securities Act all of the Preferred Registrable Securities that each such Holder has requested to be registered.
(b)    Priority on Registrations.  If a Piggyback Registration is an underwritten primary registration on behalf of the Company, and the managing underwriters determine in their sole discretion and advise the Company in writing that in their opinion the number 

1

of securities requested to be included in such registration exceeds the number which can be sold in an orderly manner in such offering within a price range acceptable to the Company, the Company shall include in such registration:  (i) first, the securities the Company proposes to sell; (ii) second, the Preferred Registrable Securities requested to be included in such registration, pro rata among the Holders on the basis of the number of Preferred Registrable Securities owned by such Holders; and (iii) third, other securities requested to be included in such registration, pro rata among the holders thereof on the basis of the number of their securities requested to be included therein.  In no event shall (i) the number of Preferred Registrable Securities be reduced below thirty percent (30%) of the total amount of securities included in such offering, unless such offering is the IPO, in which case the selling Investors may be excluded entirely if the underwriters make the determination described above and no other shareholder’s securities are included.
1.2    Demand Registrations.
(a)    At any time following the six month anniversary of the closing of an IPO, and until the fifth anniversary of the closing of an IPO, the Initiating Holders may request in writing that all or part of the Preferred Registrable Securities shall be registered for sale under the Securities Act.  Within twenty (20) days after receipt of any such request, the Company shall give written notice of such request to all other Holders, and shall include in such registration all Preferred Registrable Securities held by all such Holders who wish to participate in such demand registration and provide the Company with written requests for inclusion therein within fifteen (15) days after the receipt of the Company’s notice.  Thereupon, the Company shall effect the registration of all Preferred Registrable Securities as to which it has received requests for registration for sale, with an underwriter, selected by the Initiating Holders and reasonably acceptable to the Company.
(b)    The Company shall not be required to effect more than two (2) registrations under Section 1.2(a); provided, however, that any registration proceeding begun pursuant to Section 1.2(a) that is subsequently withdrawn at the request of the Initiating Holders shall count toward the two registration statements which the Initiating Holders have the right to cause to effect pursuant to Section 1.2(a) unless the Initiating Holders reimburse the Company for all out-of-pocket expenses incurred by the Company in connection with such withdrawn registration; provided, however, that if at the time of such withdrawal, the Initiating Holders have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Initiating Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Initiating Holders shall not be required to pay any of such expenses, such withdrawal shall not count as a registration under Section 1.2, and the Investors shall retain their rights pursuant to Section 1.2.
(c)    Notwithstanding any other provision of this Section 1.2, if any such registration contemplates an underwritten offering and if the managing underwriter advises the Initiating Holders in writing that in the managing underwriter’s opinion the number of securities requested to be included in such registration exceeds the number that can be sold in such offering without adversely affecting such underwriter’s ability to effect an orderly distribution of such securities, then the Company shall so advise all Holders that would otherwise be underwritten pursuant hereto, and the Company shall include in such registration, (i) first, the Preferred 

2

Registrable Securities requested to be included therein (the securities so included to be allocated between the Holders on a pro rata basis based on the number of Preferred Registrable Securities held by all such Holders), (ii) second, shares which the Company may wish to register for its own account, and (iii) third, other securities requested and entitled to be included in such registration; provided, however, that in any event all Preferred Registrable Securities must be included in such registration prior to any other securities of the Company.  If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter, delivered at least twenty (20) days prior to the effective date of the registration statement. Any Preferred Registrable Securities excluded or withdrawn from such underwritten public offering shall be withdrawn from the registration.
(d)    The Company shall be entitled to include in any registration statement referred to in this Section 1.2, for sale in accordance with the method of disposition specified by the Initiating Holders, shares of Common Stock to be sold by the Company for its own account, provided that the price per share applicable to such registration shall not, in the opinion of the managing underwriters (if such method of disposition shall be an underwritten public offering), be reduced due to such Common Stock to be sold by the Company.
(e)    Notwithstanding anything to the contrary in this Agreement, the Company shall not be obligated to file and cause to become effective any registration statement under this Section 1.2 or under Section 1.3 below (i) within a period of 180 days after the effective date of any registration statement of the Company (other than any registration statement on Form S-4 (or any successor form) or relating to any employee stock option or stock purchase or similar plan or relating to any dividend reinvestment plan) under the Securities Act; (ii) if the Company provides notice to the Initiating Holders within 15 days of the request for a registration that the Company is engaged in pursuing an underwritten public offering of its stock (the “Competing Offering”) in which the Initiating Holders may include Preferred Registrable Securities pursuant to Section 1.1 hereof; provided, however, the Company’s obligation to file and cause to become effective a registration statement under this Section 1.2 or under Section 1.3 below shall be reinstated if the Company does not file a registration statement with respect to the Competing Offering with the Securities and Exchange Commission within 90 days after it so notifies the Initiating Holders) and provided that the Company is actively employing in good faith all reasonable efforts to cause such registration statement to become effective; or (iii) if the Company provides to the Initiating Holders a certificate signed by the Chief Executive Officer of the Company stating that, in the good faith judgment of the Company’s Board of Directors (the “Board”), it would be seriously detrimental to the Company and its stockholders for a prospectus or registration statement (as applicable) to be filed at such time and it is therefore appropriate to defer the filing of such prospectus or registration statement, in which case the Company may direct that such request for a registration be delayed for a period not in excess of 90 days, provided that such right to delay a request may be exercised by the Company no more than once in any twelve month period and provided further that the Company shall not register any securities for the account of itself or any other stockholder during such ninety (90) day period.
(f)    Following the effectiveness of a registration statement (and the filings with any state securities commissions) filed under this Section 1.2 or under Section 1.3 below, the 

3

Company may (in the good faith judgment of the Board), subject to the provisions of Section 1.2(g), direct the Holders to suspend sales of the Preferred Registrable Securities under such registration statement for such times as the Company reasonably may determine is necessary and advisable, (i) not to exceed in any event 90 days, and (ii) not to be used more than once in any twelve (12) month period, for any event for which disclosure may be required under the securities laws, including the following events (a “Suspension Event”):  (i) an underwritten primary offering by the Company where the Company is advised by the underwriters for such offering that sale of Preferred Registrable Securities under the registration statement would have a material adverse effect on the primary offering, or (ii) pending negotiations relating to or consummation of, a transaction or the occurrence of an event (x) that would require additional disclosure of material information by the Company in the registration statement (or such filings), (y) as to which the Company has a bona fide business purpose for preserving confidentiality or (z) which renders the Company unable to comply with Commission requirements, or (iii) the continued effectiveness of a registration statement would have a material adverse effect on any proposed or pending acquisition, merger, business combination or other material transaction involving the Company, in each case under circumstances that would make it impractical or inadvisable to cause the registration statement (or such filings) to become effective or to promptly amend or supplement the registration statement on a post-effective basis, as applicable.
(g)    In the case of an event which causes the Company to suspend the effectiveness of a registration statement filed under Section 1.2 or under Section 1.3, the Company, if it wishes to exercise its right to suspend the sale of securities, shall give notice (a “Suspension Notice”) to the Holders to suspend sales of the Preferred Registrable Securities under such registration statement so that the Company may correct or update the registration statement (or such filings).  Each Holder agrees that it will not effect any sales of the Preferred Registrable Securities pursuant to such registration statement (or such filings) at any time after it has received a Suspension Notice from the Company.  If so directed by the Company, each Holder will deliver to the Company all copies of the prospectus covering the Preferred Registrable Securities held by it at the time of receipt of the Suspension Notice.  The Holders may recommence effecting sales of the Preferred Registrable Securities pursuant to the registration statement (or such filings) following further notice to such effect (an “End of Suspension Notice”) from the Company, which End of Suspension Notice shall be given by the Company as soon as practicable following the conclusion of any Suspension Event and the effectiveness of any required amendment or supplement to the registration statement.  The period of effectiveness of the registration that is subject to suspension under this Section shall be extended for a period equal to the length of the suspension.  The Company may not provide a Suspension Notice and exercise its rights of suspension hereunder if its executive officers and directors are at such time permitted to engage in trades of the Company’s Common Stock (other than pursuant to a Rule 10b5-l trading plan).
1.3    S-3 Registration Rights.
(a)    Upon and any time after the Company becomes eligible to file a registration statement on Form S-3, the Company shall, at the request from the holders of forty percent (40%) or more of the Preferred Registrable Securities (the “S-3 Initiating Holders”) then outstanding that the Company effect a registration on Form S-3 with respect to Preferred Registrable 

4

Securities, within twenty (20) days after receipt of any such request, give written notice of the proposed registration to all other Holders, and include in such registration all Preferred Registrable Securities held by all such Holders who wish to participate in such registration and provide the Company with written requests for inclusion therein within fifteen (15) days after the receipt of the Company’s notice.  Thereupon, the Company shall effect such registration as may be so requested and as would permit or facilitate the sale and distribution of all such S-3 Initiating Holders’ Preferred Registrable Securities as are specified in such request, together with all or such portion of the Preferred Registrable Securities of any other holder(s) thereof joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration pursuant to this Section 1.3 if Form S-3 is not available for such offering by the S-3 Initiating Holders.
(b)    The Company shall not be required to effect more than two (2) registrations under Section 1.3 during any 12-month period; provided, however, that any registration proceeding begun pursuant to Section 1.3(a) that is subsequently withdrawn at the request of the S-3 Initiating Holders shall count toward the two registration statements which the Holders have the right to cause to effect pursuant to Section 1.3(a) in any 12-month period unless the S-3 Initiating Holders reimburse the Company for all out-of-pocket expenses incurred by the Company in connection with such withdrawn registration, and provided further that if at the time of such withdrawal, the S-3 Initiating Holders have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the S-3 Initiating Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change then the S-3 Initiating Holders shall not be required to pay any such expenses, such withdrawal shall not count as a registration under Section 1.3(a), and the Investors shall retain their rights pursuant to Section 1.3.
1.4    Holdback Agreement.
Each Holder and each Founder shall not, without the prior written consent of the managing underwriter, sell or otherwise transfer, make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale (including sales pursuant to Rule 144) of equity securities of the Company, or any securities convertible into or exchangeable or exercisable for such securities, during such period as requested by the underwriter managing the Company’s IPO beginning on the effective date of the registration statement relating to the Company’s IPO (except as part of such underwritten registration), up to a maximum of 180 days.  If requested by the underwriter, each Holder and each Founder will reaffirm the agreement set forth in this Section 1.4 in a separate writing in a form satisfactory to such underwriter.  The Company may impose stop-transfer instructions with respect to such shares of Common Stock subject to the foregoing restriction until the end of said period.  The foregoing provisions of this Section 1.4 shall apply only to the Company’s IPO, shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, shall not apply to the sale of shares acquired in the IPO (unless such shares are acquired pursuant to a directed share program and the managing underwriter requests that such shares be subject to this Section 1.4), and shall not apply to shares acquired in the open market following the IPO, and shall only be applicable to the Holders and 

5

Founders if all officers and directors and greater than one percent (1%) stockholders of the Company agree to substantially the same terms.  If any of the obligations described in this Section 1.4 or such substantially similar agreements are waived or terminated with respect to any of the securities of any such Holder, Founder, officer, director or greater than one-percent stockholder (in any such case, the “Released Securities”), the foregoing provisions shall be waived or terminated, as applicable, to the same extent and with respect to the same percentage of securities of each Holder and Founder as the percentage of Released Securities represent with respect to the securities held by the applicable Holder, Founder, officer, director or greater than one-percent stockholder. The underwriters in connection with a registration statement so filed are intended third party beneficiaries of this Section 1.4 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. 
1.5    Registration Procedures.
Whenever required under this Agreement to effect the registration of Preferred Registrable Securities, the Company shall as expeditiously as possible:
(a)    prepare and file with the Commission a registration statement with respect to such Preferred Registrable Securities and use its best commercial efforts to cause such registration statement to become and remain effective for at least 120 days, or up 9 months in the event of registration under Section 1.3 or until the distribution described in the registration statement has been completed, whichever first occurs;
(b)    notify each Holder of the effectiveness of each registration statement filed hereunder and prepare and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for such periods set forth above and comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement during such period in accordance with the intended methods of disposition by the sellers thereof set forth in such registration statement;
(c)    furnish to each seller of Preferred Registrable Securities such number of copies of such registration statement, each amendment and supplement thereto, the prospectus included in such registration statement (including each preliminary prospectus) and such other documents as such seller may reasonably request in order to facilitate the disposition of the Preferred Registrable Securities owned by such seller;
(d)    use its best commercial efforts to register or qualify such Preferred Registrable Securities under such other securities or blue sky laws of such jurisdictions as any seller reasonably requests and do any and all other acts and things which may be reasonably necessary or advisable to enable such seller to consummate the disposition in such jurisdictions of the Preferred Registrable Securities owned by such seller; provided that the Company shall not be required to:  (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this subparagraph; (ii) subject itself to taxation in any such jurisdiction; or (iii) consent to general service of process in any such jurisdiction;

6

(e)    cause all such Preferred Registrable Securities to be listed or quoted on each securities exchange or market on which similar securities issued by the Company are then listed; provided, however, that if the Company’s securities are not listed or quoted on a securities exchange or market, the Holders will not have the right to a registration under Section 1.2 or Section 1.3 of this Agreement;
(f)    provide a transfer agent and registrar and a CUSIP number for all such Preferred Registrable Securities not later than the effective date of such registration statement;
(g)    enter into such customary agreements (including underwriting agreements in customary form) in order to expedite or facilitate the disposition of such Preferred Registrable Securities and, in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering;
(h)    make available for inspection at reasonable times by any underwriter participating in any disposition pursuant to such registration statement, and any attorney, accountant or other agent retained by any such underwriter, all financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s officers, directors, employees and independent accountants to supply all information reasonably requested by any such underwriter, attorney, accountant or agent in connection with such registration statement;
(i)    subject to Section 1.5(d) above, use its reasonable efforts to cause any Preferred Registrable Securities covered by such registration statement to be registered with or approved by such other governmental agencies or authorities as may be necessary to enable the sellers thereof to consummate the disposition of such Preferred Registrable Securities;
(j)    if the offering is underwritten, use its reasonable efforts to furnish on the date that Preferred Registrable Securities are delivered to the underwriters for sale pursuant to such registration, an opinion dated such date of counsel representing the Company for the purposes of such registration and a “comfort letter” from the Company’s independent accountants, addressed to the underwriters covering such issues as are reasonably required by such underwriters; and
(k)    notify each Holder at any time when a prospectus relating thereto is required to be delivered under the Securities Act or the happening of any event as a result of which the Company reasonably believes the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing.
1.6    Registration Expenses.
(a)    Payment of Registration Expenses.  All expenses incident to the Company’s performance of or compliance with this Agreement, including without limitation all registration and filing fees, fees and expenses of compliance with securities or blue sky laws, printing expenses, messenger and delivery expenses, fees and disbursements of custodians, and fees and 

7

disbursements of counsel for the Company and all independent certified public accountants, underwriters (excluding customary fees and commissions) and other Persons retained by the Company and the reasonable fees and disbursements of one counsel selected by the majority of the Selling Stockholders, which shall not exceed $50,000 (all such expenses being herein called “Registration Expenses”), shall be borne by the Company.
(b)    Payment of Registration Expenses by Holders of Preferred Registrable Securities.  Each holder of securities included in any registration hereunder shall pay those Selling Expenses allocable to the registration of such holder’s securities so included.
1.7    Participation in Underwritten Registrations. 
No Person may participate in any registration hereunder unless such Person:
(a)    in the case of a registration which is underwritten, agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved by the Company or the Initiating Holders (as applicable for registrations under Sections 1.2 or 1.3 above);
(b)    as expeditiously as possible, notifies the Company, at any time when a prospectus relating to such Person’s Preferred Registrable Securities is required to be delivered under the Securities Act, of the happening of any event with respect to such Person known to such Person as a result of which such prospectus contains an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading;
(c)    complies with all reasonable requests made by the Company or its counsel with respect to the registration of such Person’s Preferred Registrable Securities;
(d)    completes, executes and delivers all questionnaires, powers of attorney, indemnities, underwriting agreements and other usual and customary documents necessary or appropriate with respect to the offering of such Person’s Preferred Registrable Securities, and in the case of a registration which is underwritten, necessary or appropriate under the terms of such underwriting arrangements (subject to the provision in Section 1.7(a) above); and
(e)    consents to the following conditions:  (a) conditions requiring the Investor to comply with all applicable provisions of the Securities Act and the Exchange Act including, but not limited to, the prospectus delivery requirements of the Securities Act, and to furnish to the Company information about sales made in such public offering; (b) conditions prohibiting the Investor upon receipt of telegraphic or written notice from the Company that it is required by law to correct or update the registration statement or prospectus from effecting sales of the Preferred Registrable Securities until the Company has completed the necessary correction or updating; and (c) conditions prohibiting the sale of Preferred Registrable Securities by such Investor, as the case may be, during the process of the registration until the Registration Statement is effective.
1.8    Indemnification. In the event any Preferred Registrable Securities are included in a registration statement under this Section 1:

8

(a)    To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, members, officers, directors and shareholders of each Holder, its legal counsel, accountants and investment advisers, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act (collectively and individually referred to as the “Indemnified Party”), against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or any state securities laws, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):  (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus, final prospectus or Free Writing Prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any state securities laws or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities laws; and the Company will reimburse each such Indemnified Party for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 1.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable to an Indemnified Party in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by any such Indemnified Party; provided further, however, that the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of any Indemnified Party, from whom the person asserting any such losses, claims, damages or liabilities purchased shares in the offering, if a copy of the prospectus (as then amended or supplemented if the Company shall have furnished any amendments or supplements thereto) was not sent or given by or on behalf of such Indemnified Party, if required by law so to have been delivered, at or prior to the written confirmation of the sale of the shares to such person, and if the prospectus (as so amended or supplemented) cured the defect giving rise to such loss, claim, damage or liability. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Party.
(b)    To the extent permitted by law, each selling Holder will severally and not jointly indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act or any state securities laws, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information 

9

furnished by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any person intended to be indemnified pursuant to this subsection 1.8(b) for any legal or other expenses reasonably incurred by such person in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this subsection 1.8(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), and further provided that in no event shall any indemnity under this subsection 1.8(b) exceed the net proceeds from the offering received by such Holder;
(c)    Promptly after receipt by an indemnified party under this Section 1.8 of notice of the commencement of any action (including any governmental action) involving the subject matter of the foregoing indemnity provisions, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.8. deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one (1) separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding.  The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 1.8 to the extent of such prejudice, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.8. After notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the indemnifying party will not be liable to such indemnified party pursuant to the provisions of this Section 1.8 for any legal or other expense subsequently incurred by such indemnified party in connection with the defense thereof, unless (i) the indemnified party shall have employed separate counsel in accordance with the provision of the first sentence of this Section 1.8(c), or (ii) the indemnifying party has authorized in writing the employment of counsel for the indemnified party at the expense of the indemnifying party. No indemnifying party will consent to entry of any judgment or enter into any settlement, which does not include as a term thereof the giving by the claimant or plaintiff to such indemnified party a release from liability in respect to such claim or litigation;
(d)    If the indemnification provided for in this Section 1.8 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other, in connection with the statements or omissions that resulted in such 

10

loss, liability, claim, damage or expense, as well as any other relevant equitable considerations; provided, however, that no contribution by any Holder, when combined with any amounts paid by such Holder pursuant to Section 1.8(b), shall exceed the net proceeds from the offering received by such Holder.  The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission;
(e)    Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control; and
(f)    The obligations of the Company and Investors under this Section 1.8 shall survive the completion of any offering of Preferred Registrable Securities in a registration statement under this Section 1, and otherwise.
1.9    Reports Under Securities Exchange Act of 1934.  With a view to making available to the Holder the benefits of Rule 144 and any other rule or regulation of the Commission that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to:
(a)    make and keep adequate current public information available, as those terms are understood and defined in Rule 144, at all times after the effective date of the IPO;
(b)    file with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act; and
(c)    furnish to any Investor, so long as the Investor owns any Preferred Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement filed by the Company), the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Investor of any rule or regulation of the Commission that permits the selling of any such securities without registration or pursuant to such form.
1.10    Assignment of Registration Rights; Termination of Rights.  The rights to cause the Company to register Preferred Registrable Securities pursuant to this Agreement may be assigned (but only with all related obligations) by a holder to a transferee or assignee of such securities provided that such transfer or assignment is made pursuant to the provisions of the Company’s Amended and Restated Certificate of Incorporation, as amended, and any other provisions relating to transfer of securities, and provided further that:  (a) the Company is, within 

11

a reasonable time after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; and (b) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement.  All rights granted under Section 1 will expire and this Agreement will be terminated on the earlier of (i) the seventh anniversary of the IPO, (ii) the closing of a Deemed Winding Up, as such term is defined in the Company’s Amended and Restated Certificate of Incorporation, as amended and (iii) for any individual Investor, such time as Rule 144 or another similar exemption under the Securities Act is available for the sale of all such Holder’s shares without limitation during a three-month period without registration (and without the requirement for the Company to be in compliance with the current public information required under Rule 144(c)(1)).
1.11    Limitation on Subsequent Registration Rights.  After the date of this Agreement, the Company shall not, without the prior written consent of the holders of at least 55% of the Preferred Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company which would allow to (a) include such securities in any registration filed under Section 1 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will not reduce the amount of the Preferred Registrable Securities of the Holders that are included and shall be subordinated to the rights of any Holder hereunder or (b) demand registration of their securities, including without limitation, on Form S-3.
1.12    Foreign Offerings.  The provisions of Section 1 shall apply, to the extent applicable, mutatis mutandis, to any registration of securities of the Company outside of the United States of America.
2.    Information, Reporting and Covenants.
2.1    Information and Reporting Rights.
(a)    Each holder of Preferred Stock holding at least 1,000,000 shares of Preferred Stock (calculated on an as converted basis and as adjusted for any stock splits, stock dividends, recapitalizations or the like) and each Wellington Investor (each, an “Eligible Holder”), shall be entitled to receive the following information from the Company:
(i)    Annual Reports.  As soon as practicable, but in any event within 120 days after the end of each fiscal year of the Company, (i) a balance sheet of the Company as at the end of such fiscal year, (ii) statements of income and cash flows of the Company for such year, and a comparison between (x) the actual amounts as of and for such fiscal year and (y) the comparable amounts for the prior year and (iii) a statement of stockholders’ equity as of the end of such year, all such financial statements prepared in accordance with United States generally accepted accounting principles (“GAAP”), all in reasonable detail and audited by one of the “big four” independent public accountants of nationally recognized standing, such firm to be selected by the Company (the “Accounting Firm”), provided that such unaudited financial statements shall be prepared by the Company within 60 days after the end of the fiscal year;

12

(ii)    Quarterly Reports.  As soon as practicable, but in any event within forty-five (45) days after the end of each of the three (3) quarters of each fiscal year, unaudited but reviewed statement of income and cash flow for such fiscal quarter and a balance sheet and a statement of stockholders’ equity as of the end of such quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be required in accordance with GAAP), and such additional information and commentary as may be reasonably requested by an Eligible Holder;
(iii)    as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock and securities convertible into or exercisable for shares of capital stock outstanding at the end of the period, the Common Stock issuable upon conversion or exercise of any outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price applicable thereto, and the number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to permit the Eligible Holders to calculate their respective percentage equity ownership in the Company;
(iv)    Monthly Management Reports.  As soon as practicable, but in any event within thirty (30) days after the end of each month, a monthly management report containing such information as shall be agreed in writing between the Company and Eligible Holders holding a majority of the Preferred Stock, including without limitation, orders, cash, burn and estimated revenues; and
(v)    Budget. Within thirty (30) days after approval by the Board, a budget and business plan for the next fiscal year (collectively, the “Budget”), approved by the Board, prepared on a monthly basis including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company.
(vi)    Additional Information.  Such other information relating to the financial condition, business, or corporate affairs of the Company as may be reasonably requested by such Eligible Holders; provided, however, that the Company shall not be obligated under this subsection (vi) to provide information that it deems in good faith to be a trade secret or similar confidential information (unless covered by an enforceable confidentiality agreement, in a form acceptable to the Company).
If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries.
2.2    Access and Visitation Rights. The Company will permit one authorized representative of each Eligible Holder (i) to visit, inspect and copy the Company’s properties, including but not limited to the Company’s corporate and financial records, and (ii) to discuss the 

13

Company’s business with the Company’s officers during normal business hours, provided that such authorized representatives give the Company prior written reasonable notice prior to such visit and the visit occurs at a reasonable time.  All such information obtained or reviewed by such representative shall be subject to Section 9 of this Agreement.
2.3    Common Stock Vesting.  Unless otherwise agreed by the Board or the compensation committee of the Board, which shall include the affirmative vote of at least 2 of the Investor Directors, Common Stock (or options to purchase Common Stock) issued to employees of the Company will be subject to four-year vesting, with 25% of such shares vesting after 12 months of continuous service to the Company and the balance vesting on a monthly basis over an additional 36 months.  Such shares shall also be subject to a right of first refusal in favor of the Company. 
2.4    “Bad Actor” Notice.  Each party to this Agreement that is a Company Covered Person will promptly notify each other party to this Agreement in writing if it or, to its knowledge, any other Company Covered Person becomes subject to any Bad Actor Disqualification.
2.5    Termination. The provisions of this Section 2 shall terminate automatically upon the earlier to occur of (i) the consummation of the Company’s IPO or (ii) when the Company first becomes subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the Exchange Act, whichever event shall first occur.
3.    Preemptive Rights.
The Company hereby grants to each Investor and Founder (collectively, the “Rights Holders”) the preemptive right (the “Preemptive Right”) to purchase up to his/her/its Pro Rata Share (as defined below) of any New Securities (as defined below) that the Company may, from time to time propose to sell and issue.  “Pro Rata Share” shall mean, for purposes of this Preemptive Right, is the ratio between (x) the aggregate number of shares of Common Stock then owned by a Rights Holder (on an as converted to Common Stock basis), to (y) the aggregate number of shares of Common Stock then issued and outstanding by all of the Company’s securityholders (on an as converted to Common Stock basis).  The Preemptive Right shall be subject to the following provisions:
(a)    In the event that the Company proposes to undertake an issuance of New Securities, it shall give each Rights Holder written notice of its intention, describing the type of New Securities, the price, and the general terms upon which the Company proposes to issue the same (the “Issuance Notice”).  The Rights Holders shall have fourteen (14) days (the “Notice Period”) after delivery of such notice to agree to purchase all or any part of his/her/its Pro Rata Share of such New Securities for the same price and upon the same terms specified in the Issuance Notice, by giving written notice to the Company setting forth the number of New Securities such Rights Holder elects to purchase.
(b)    The Company shall promptly inform in writing each Rights Holder that (i) elects to purchase all of his/her/its Pro Rata Share of the New Securities and (ii) that holds at least 2,250,000 shares of Common Stock (on an as converted to Common Stock basis and as adjusted for any stock splits, stock dividends, recapitalizations or the like) (a “Fully-Exercising 

14

Investor”) of any other Rights Holder’s failure to do likewise.  During the seven (7) day period commencing after such information is given, each Fully-Exercising Investor may elect to purchase the balance of the New Securities for which Rights Holders were entitled to subscribe but which were not subscribed for by the Rights Holders that is equal to the proportion that the number of shares of Common Stock issued and held (on an as converted to Common Stock basis) by such Fully-Exercising Investor bears to the total number of shares of Common Stock issued and held (on an as converted to Common Stock basis) by all Fully-Exercising Investors who wish to purchase some of the unsubscribed shares.
(c)    Any Rights Holder who does not inform the Company in writing, within 14 days after receipt of the Issuance Notice, of his/her/its election to exercise all or a portion of his/her/its Preemptive Right shall be deemed to have waived his/her/its right to purchase his/her/its Pro Rata Share of the New Securities being offered.  In the event that all of the Rights Holders fail to exercise their full Preemptive Right (including the right to overallotment), the Company shall have ninety (90) days thereafter to sell any portion of the New Securities not subscribed for by the Rights Holders (the “Unsubscribed New Securities”) Shares at a price and upon terms no more favorable to the purchasers thereof than specified in the Issuance Notice.  In the event the Company has not sold the Unsubscribed New Securities within such ninety (90) day period the Company shall not thereafter issue or sell any Unsubscribed New Securities, without first offering such Unsubscribed New Securities to the Rights Holders in the manner provided above.
(d)    For purposes of this Section 3, the term “New Securities” shall mean any equity interest (including shares of Common Stock and Preferred Stock) in the Company, whether now authorized or not, and rights, options or warrants to purchase such equity interests, and securities of any type whatsoever that are convertible into equity interests; provided that the term “New Securities” does not include Exempted Securities (as defined in the Company’s Amended and Restated Certificate of Incorporation, as amended).
(e)    The Preemptive Right granted under this Section 3 shall expire upon the earlier to occur of (i) immediately prior to the closing of an IPO or (ii) upon a Deemed Winding Up, as such term is defined in the Company’s Amended and Restated Certificate of Incorporation, as amended.        
4.    Right of First Refusal.
(a)    Prior to an IPO or Deemed Winding Up, in the event that any Founder or Investor (the “Selling Stockholder”) desires to sell, assign, transfer, pledge, hypothecate or otherwise encumber or dispose of in any way (hereinafter referred to as “Transfer”) any or all of the shares of capital stock of the Company held by such Selling Stockholder (the “Offered Shares”) other than to a Permitted Transferee as defined in Section 10 herein, and provided such Transfer is permitted in accordance with Section 5 below, it shall first give written notice thereof (“Notice of Sale”) to the Company, and then, if the Company does not exercise its right to purchase all or any portion of the Offered Shares, the Company shall immediately thereafter provide the Notice of Sale to each Investor and Founder other than the Selling Stockholder (together, the “Offerees”).

15

(b)    The Notice of Sale shall state the material terms and conditions (including the number of Offered Shares, the name(s) of the prospective buyer(s), the intended date of the proposed Transfer, the price and form of consideration) for the Offered Shares as submitted to the Selling Stockholder.
(c)    The Company (or its assignees) shall, for a period of seven (7) days following receipt of the Notice of Sale have the right to purchase all or any portion of the Offered Shares upon the same terms and conditions specified in the Notice of Sale.  The Company may exercise such right only if approved by the Company’s Board, including by the affirmative approval of at least two of the Investor Directors.
(d)    For a period of fourteen (14) days after receipt of the Notice of Sale from the Company, the Offerees may elect to purchase up to their Pro Rata Share (as defined below) of the Offered Shares not purchased by the Company pursuant to Section 4(c) (the “Remaining Offered Shares”), by delivery of a notice (the “Response Notice”) to such effect to the Selling Stockholder (with a copy to the Company) within fourteen (14) days of receipt of the Notice of Sale; provided, however, that each Offeree may exercise his/her/its right only if he/she/it represents in the Response Notice that he/she/it is acquiring the Remaining Offered Shares for investment for his/her/its own account, and not for resale to any third party (other than a Permitted Transferee).  The election to purchase any Remaining Offered Shares shall be irrevocable by the Offeree, once the Response Notice is delivered to the Selling Stockholder.  If more than one of the Offerees exercises such option (the “Buying Stockholders”), each Buying Stockholder shall acquire his/her/its Pro Rata Share of the Remaining Offered Shares as defined below, or such other ratio of the Remaining Offered Shares as the Buying Stockholders may agree to between themselves.  For the purpose of this Section 4, a Buying Stockholder’s “Pro Rata Share” shall mean the ratio between (x) the aggregate number of shares of Common Stock then held by such Buying Stockholder (on an as converted to Common Stock basis), and (y) the aggregate number of shares of Common Stock (on an as converted to Common Stock basis) held by all Buying Stockholders, as of the date immediately prior to the Notice of Sale.  The purchase of the Remaining Offered Shares shall be on the same terms and conditions as stated in the Notice of Sale.  Each Buying Stockholder shall have a right of overallotment such that, if any other Offeree fails to exercise his/her/its right to purchase its full Pro Rata Share of the Remaining Offered Shares, the other participating Buying Stockholders may purchase, on a pro rata basis among all Buying Stockholders, the Remaining Offered Shares not previously purchased for a period of five (5) business days following the receipt of a notice from the Company notifying such Buying Stockholders of the other Offerees’ failure to so participate.
(e)    If the Offerees fails to exercise the right of first refusal provided for above in respect of all of the Remaining Offered Shares, then, subject to Section 6 below, the Selling Stockholder shall be free, within ninety (90) days of the date of expiration of the foregoing periods, to sell such Offered Shares not purchased by the Company or the Buying Stockholders hereunder to the prospective buyer(s) identified in the Notice of Sale at a price and in accordance with terms as specified in the Notices of Sale.  If such Offered Shares are not Transferred within such ninety (90) day period, the Selling Stockholder shall not Transfer the Offered Shares without again being subject to the provisions of this Section 4.

16

5.    Restrictions on Transfer; Permitted Transfers.
(a)    Until the earlier of (i) the Company’s IPO; or (ii) the Company’s Deemed Winding Up (as such term is defined in the Company’s Amended and Restated Certificate of Incorporation, as amended from time to time), each of the Founders and Investors holding at least 225,000 shares of Common Stock (on an as converted to Common Stock basis and as adjusted for any stock splits, stock dividends, recapitalizations or the like) (a “Transferring Stockholder” and collectively the “Transferring Stockholders”), will not Transfer all or any part of or any interest in any equity securities of the Company now or hereafter owned or held by such Transferring Stockholder, without the prior written approval of the Board, including the affirmative approval of all the Investor Directors. 
(b)    Notwithstanding the provisions contained in Section 4, Section 5(a) and Section 6 of this Agreement, each Transferring Stockholder or Permitted Transferee of a Transferring Stockholder shall be permitted to Transfer of all or any part of the Common Stock, held by such Transferring Stockholder or a Permitted Transferee of a Transferring Stockholder to any Permitted Transferee.
(c)    Any Transfer of equity securities in accordance with Section 5(a) or Section 5(b) shall not be effective unless the transferee agrees in writing to remain subject to all of the limitations and obligations which apply to such equity securities hereunder, and/or the Company’s Amended and Restated Certificate of Incorporation and/or Bylaws, each, as amended from time to time.
(d)    In the event that any of the Founders or Investors should Transfer any shares of the Company’s capital stock in contravention of this Agreement (a “Prohibited Transfer”), such Prohibited Transfer shall be null and void and the Company shall not effect any transfer of shares which constitutes a Prohibited Transfer.
6.    Co-Sale.
(a)    Prior to an IPO or Deemed Winding Up, in the event that a Selling Stockholder holding at least 225,000 shares of Common Stock (on an as converted to Common Stock basis and as adjusted for any stock splits, stock dividends, recapitalizations or the like, for purposes of this Section 6, the “Seller”) proposes to Transfer any shares of the Company’s capital stock then held by such Seller (the “Co-Sale Stock”) (other than to a Permitted Transferee) and (ii) the rights of first refusal set forth in Section 4 are not fully exercised, the Seller shall give each Investor (a “Co-Sale Rights Holder”) a written notice stating the material terms and conditions (including the number of Co-Sale Stock, the name of the prospective buyer(s), the intended date of the proposed Transfer, the price and form of consideration) (the “Co-Sale Notice”).  Seller may not Transfer any of the Co-Sale Stock until each of the Co-Sale Rights Holders shall have been given the opportunity, exercisable within fourteen (14) days from the date of receipt of the Co-Sale Notice to the Co-Sale Rights Holders, to Transfer to prospective buyer(s), upon the same terms and conditions set forth in the Co-Sale Notice, all or any part of its Co-Sale Pro Rata Share (as defined below) of the Co-Sale Stock.  Co-Sale Rights Holders who fail to notify the Seller within fourteen (14) days after receipt of the Co-Sale Notice shall be deemed to have waived their rights in full 

17

pursuant to this Section 6.  The term “Co-Sale Pro Rata Share” means the ratio between (x) the number of shares of Common Stock owned by such Co-Sale Rights Holder (on an as converted to Common Stock basis) on the date of the Co-Sale Notice, and (y) the aggregate number of shares of Common Stock (on an as converted to Common Stock basis) owned by all Co-Sale Rights Holders on the date of the Co-Sale Notice plus the total number of shares of Common Stock (on an as converted to Common Stock basis) owned by the Seller.
(b)    To the extent one or more of the Co-Sale Rights Holders exercises his/her/its co-sale right set forth above, the number of shares of Co-Sale Stock that the Seller may sell in the transaction shall be correspondingly reduced.  To the extent that any prospective buyer(s) prohibits assignment or otherwise refuses to purchase shares or other securities from a Co-Sale Rights Holder exercising its rights of co-sale hereunder, the Seller shall not Transfer to such prospective buyer(s) any Co-Sale Stock unless and until, simultaneously with such Transfer, the Seller shall purchase such shares or other securities from such Co-Sale Rights Holder on the same terms and conditions specified in the Co-Sale Notice.
7.    Board of Directors; Committees.
(a)    The Company’s Board shall consist of a number of directors as determined by the Board, to be elected as follows:
(i)    With respect to the one (1) member of the Company’s Board that the Amended and Restated Certificate of Incorporation provides is to be elected by the holders of the Common Stock, the Founders and the Investors hereby agree to vote all of their shares of Common Stock now owned or hereafter acquired in favor of the election of a person designated by the Founders and Investors holding of a majority of the Common Stock as of the date of record for such annual or special meeting who shall either be (i) one of Yehezkel Yeshurun, Doron Shikmoni or Oded Comay, or (ii) an individual that is approved by at least two (2) of the Investor Directors (such approval not to be unreasonably withheld).  The representative of the Common Stock shall initially be Yehezkel Yeshurun, the current Chairman of the Company.  Any vacancy occurring because of the death, resignation, or removal of the above elected director shall be filled according to this Section 7(a)(i).
(ii)    With respect to those two (2) members of the Company’s Board that the Amended and Restated Certificate of Incorporation provides are to be elected by the holders of Series B Preferred Stock, the Founders and the Investors hereby agree to vote all of their shares of Series B Preferred Stock now owned or hereafter acquired in favor of (i) one director designated by Accel Partners (the “Accel Director”), which shall, as of the date of this Agreement, be vacant and (ii) one director designated by Pitango (the “Pitango Director”), which director shall initially be Rami Kalish.  Any vacancy occurring because of the death, resignation, or removal of the above elected directors shall be filled according to this Section 7(a)(ii).
(iii)    With respect to the member of the Company’s Board that the Amended and Restated Certificate of Incorporation provides is to be elected by the holders of Series D Preferred Stock, the Founders and the Investors hereby agree to vote all of their 

18

shares of Series D Preferred Stock now owned or hereafter acquired in favor of a director designated by Amadeus (the “Amadeus Director” and together with the Accel Director and the Pitango Director, the “Investor Directors”), which director shall initially be Richard Anton.  Any vacancy occurring because of the death, resignation, or removal of the above elected directors shall be filled according to this Section 7(a)(iii).
(iv)    With respect to the remaining members of the Company’s Board that the Amended and Restated Incorporation provides are to be elected by the holders of Common Stock, Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, the Series D Preferred Stock, Series E Preferred Stock, Series E-1 Preferred Stock, Series E-2 Preferred Stock, Series F Preferred Stock and Series G Preferred Stock (voting together as a single class and on an as converted basis), the Founders and the Investors hereby agree to vote all of their shares of Common Stock and Preferred Stock now owned or hereafter acquired in favor of (a) the then-current Chief Executive Officer of the Company (the “CEO Director”), and (b) with respect to all other directors, at least one of whom shall be a non-executive independent director (the “Independent Directors”), and each of whom shall be designated by the unanimous resolution of all the members of the Board (other than the Independent Directors).  Any vacancy occurring because of the death, resignation, or removal of the above elected directors shall be filled according to this Section 7(a)(iv).  Initially, the CEO Director shall be Michael DeCesare, and initially the Independent Directors shall be David DeWalt, Kent Elliot, Mark Jensen, Enrique Salem and Theresia Gouw.
(b)    In any and all elections of directors of the Company (whether at a meeting or by written consent in lieu of a meeting), the Founders and Investors shall vote or cause to be voted all shares of stock owned by him, her or it, or over which he, she or it has voting control, and otherwise use his, her or its respective best efforts, so as to elect the directors as set forth in Section 7(a) above.  At any annual or special meeting called, or any other action taken, for the purpose of electing to or removing directors from the Board, the Founders and Investors agree to vote all of their equity securities in the Company during the term of this Agreement, so as to always cause the Board to be constituted as set forth above, whether by election of a designee or by removal or replacement of a designee at the request of the party or parties entitled to designate such designee.
(c)    Until an IPO, Mr. Benny Bergman, Mr. Tomer Lindor, a designee of Meritech Capital Partners II L.P. (the “Meritech Observer”) and a designee of the Wellington Investors (the “Wellington Observer”) shall serve as observers to the Board.  As observers, Mr. Bergman, Mr. Tomer Lindor, the Meritech Observer and the Wellington Observer shall be invited to attend all meetings of the Board, including executive sessions, in a nonvoting observer capacity and, in this respect, shall be given copies of all notices, minutes, consents, and other materials that the Company provides to its directors; provided, however, that all information provided by the Company to such observers shall be subject to Section 9 of this Agreement; and, provided further, that the Company reserves the right to withhold any information and to exclude any such observer from any meeting or portion thereof if (i) access to such information or attendance at such meeting could reasonably be determined to adversely affect the attorney-client privilege between the Company and its counsel, or (ii) such exclusion is reasonably necessary to protect highly confidential 

19

proprietary information, including protection from disclosure of trade secrets, or (iii) such observer is affiliated with a direct competitor of the Company.  The Company shall reimburse Meritech Capital Partners II L P. for the reasonable expenses incurred by it and the Meritech Observer in connection with attendance at meetings of the Board. The Company shall reimburse the Wellington Investors for the reasonable expenses incurred by them and the Wellington Observer in connection with attendance at meetings of the Board.
(d)    Chairman of the Board of Directors.  The Chairman of the Board will be elected and removed from time to time by a majority resolution of the Board.
(e)    Covenants of the Company.  The Company agrees to use its best efforts to ensure that the rights granted under this Section 7 are effective and that the parties enjoy the benefits thereof.  Such actions include, without limitation, the use of the Company’s best efforts to cause the nomination and election of the directors as provided above.  The Company will not, by any voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all of the provisions of this Agreement and in the taking of all such actions as may be necessary, appropriate or reasonably requested by the Founders and the Investors in order to protect the rights of the Founders and the Investors hereunder against impairment.
(f)    Successor Directors and Removal of Directors.
(i)    If a director ceases to serve for any reason, the Person which is entitled to designated such director, in accordance with the provisions of Section 7(a), shall have the right to designate a successor and each of the other parties hereto agrees to vote in favor of that successor.
(ii)    If the Person entitled to designate a director hereunder elects to remove such director for any reason, then such entities, in accordance with the provisions of Section 7(a) hereof, shall have the right to remove the director and designate a successor and each of the other parties hereto agrees to vote in favor of the removal of that director and the election of his or her successor.
(iii)    In the event that the CEO Director ceases to serve as Chief Executive Officer of the Company, each of the parties hereto agrees to vote in favor of the removal of such person as the CEO Director and that the election of any successor Chief Executive Officer of the Company as CEO Director.
(g)    Meetings of the Board.  Unless otherwise agreed to by the Board, including the agreement of at least two Investor Directors, the Board will meet at least four (4) times per calendar year, with at least two (2) meetings to be held in person of which at least one (1) meeting will take place in Israel or the United Kingdom and at least one (1) meeting will take place in California.  The management of the Company will submit and distribute to all the Board members a report (in such format to be determined by the Board) before each such Board meeting and will use its reasonable efforts to provide such report at least one week in advance of such meeting.

20

(h)    No Liability for Election of Recommended Directors.  Neither the parties hereto nor any officer, director, stockholder, member, partner, employee or agent of any such party, makes any representation or warranty as to the fitness or competence of the designee of any party hereunder to serve on the Board by virtue of such party’s execution of this Agreement or by the act of such party in voting for such designee pursuant to this Agreement.
(i)    Director Expenses.  The Company shall reimburse all the Investor Directors for all reasonable expenses incurred in their service as such, in compliance with the Company’s travel and expense reimbursement policies as may be in effect from time to time.
(j)    If the Board elects to create a compensation committee, an audit committee or any other committee to the Board, such committee shall include at least one (1) of the Investor Directors.
(k)    Special Approval Rights.  Without derogating from the provisions of the Company’s Amended and Restated Certificate of Incorporation (as amended from time to time), until the earlier of the closing of an IPO or a Deemed Winding Up (as such term is defined in the Company’s Amended and Restated Certificate of Incorporation, as amended), the Company shall not, without the approval of the Board of Directors, including the affirmative approval of at least two (2) of the Investor Directors, take any of the following actions:
(1)    approve or make any material change to the annual budget or business plan of the Company;
(2)    approve or incur, or permit any subsidiary to approve or incur, any expenditure or commitment not provided for in the Company’s, or such subsidiary’s, annual budget and operating plan in excess of US $500,000; or
(3)    approve or incur or permit any subsidiary to approve or incur, any credit line, lease or other indebtedness with a bank or similar institution in excess of US $1,000,000, other than short term lines of credit established in the ordinary course of business.
(l)    Termination.  The provisions of this Section 7 shall expire upon the earlier of (i) the consummation of the Company’s IPO and (ii) a Deemed Winding Up (as such term is defined in the Company’s Amended and Restated Certificate of Incorporation, as amended).
8.    Directors Insurance.
8.1    Until an IPO, the Company shall procure and maintain in effect customary directors and officers insurance policies, with amounts of coverage as shall be determined by the Board of the Company, which amount shall be at least US $2,500,000, unless otherwise approved by the Board (including at least two Investor Directors).
9.    Confidentiality; Publicity. 

21

(a)    Each Investor acknowledges and agrees that the information received by it pursuant to the G Purchase Agreement (and related schedules and exhibits) and this Agreement may be confidential and for its use only, and it will not use such confidential information in violation of the Exchange Act or reproduce, disclose or disseminate such information to any other person, except (a) in connection with the exercise of rights under this Agreement, (b) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company, (c) to any affiliated entity, partner (and partners of such partner), member, or wholly-owned subsidiary of such Investor, in the ordinary course of business, provided that such Investor informs such persons or entities that such information is confidential and directs such person or entity to maintain the confidentiality of such information, (d) at such time as such information enters the public domain through no fault of such Investor, (e) if such information is communicated to it free of any obligation of confidentiality, (f) if such information is or has been independently developed or conceived by such Investor without use of the Company’s confidential information, or (g) as required under applicable law. Notwithstanding the foregoing, in the case of any Wellington Investor, such Wellington Investor may identify the Company and the value of such Wellington Investor’s security holdings in the Company in accordance with applicable investment reporting and disclosure regulations or internal policies and respond to routine examinations, demands, requests or reporting requirements of a regulator without prior notice to or consent from the Company. 
(b)    The Company agrees that it will not, and shall cause each of its subsidiaries to not, without the prior written consent of the Wellington Investors, use in advertising, publicity, or otherwise the name of Wellington, any Wellington Investor, or any partner or employee of Wellington or any Wellington Investor, nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by Wellington, any Wellington Investor or any of their respective affiliates (collectively, the “Wellington Information”); provided, however, that the Company may, without the prior written consent of any person, disclose any Wellington Information if required to be disclosed by the Company pursuant to law (including, but not limited to any documents required to be publicly disclosed in, or as exhibits to, a registration statement in connection with the Company’s IPO) or by a court of competent jurisdiction, pursuant to the requirements of a stock exchange, the Securities and Exchange Commission or other governmental or regulatory body or to obtain tax or other clearance or consent from any relevant authority. For the avoidance of doubt, the Company may disclose any Wellington Information to any Permitted Recipient (as defined below). The term “Permitted Recipient” means (i) any of the Company’s attorneys, accountants, directors, board observers, stockholders, lenders or advisors, (ii) any of the Company’s employees with a need to know any of the Wellington Information, and (ii) any of the Company’s potential acquirors, investors or lenders or any of their respective counsel or advisors, in each case bound by fiduciary duties, confidentiality obligations or otherwise prohibited from disclosing any of the Wellington Information..  Notwithstanding the foregoing, the Company and the Wellington Investors have agreed to announce the Wellington Investors’ investment in the Company within a reasonable time after the Initial Closing of the sale of the Series G Preferred Stock pursuant to the G Purchase Agreement in a statement that is mutually agreeable to the Company and the Wellington Investors, which statement shall contain the identity of Wellington, as investment adviser to the Wellington Investors, and certain other Investors.

22

10.    Definitions.
(a)    The term “A Investors” means each of the Series A Preferred stockholders with respect to such Series A Preferred Stock held by them.
(b)    The term “B Investors” means each of the Series B Preferred stockholders with respect to such Series B Preferred Stock held by them.
(c)    The term “C Investors” means each of the Series C Preferred stockholders with respect to such Series C Preferred Stock held by them.
(d)    The term “D Investors” means each of the Series D Preferred stockholders with respect to such Series D Preferred Stock held by them.
(e)    The term “E Investors” means each of the Series E Preferred stockholders with respect to such Series E Preferred Stock held by them.
(f)    The term “E-1 Investors” means each of the Series E-1 Preferred stockholders with respect to such Series E-1 Preferred Stock held by them.
(g)    The term “F Investors” means each of the Series F Preferred stockholders with respect to such Series F Preferred Stock held by them.
(h)    The term “G Investors” means each of the Series G Preferred stockholders with respect to such Series G Preferred Stock held by them.
(i)    The term “Accel Partners” means Accel VIII, L.P., Accel Internet Fund IV, L.P. and Accel Investors 2000 L.L.C. and their Permitted Transferees.
(j)    The term “Amadeus” means Amadeus II ‘A’, Amadeus II ‘B’, Amadeus II ‘C’, Amadeus II ‘D’ GmbH & Co KG, Amadeus II Affiliates Fund LP, Amadeus IV Velocity Fund L.P., Amadeus EI L.P., Amadeus EII L.P. and their Permitted Transferees.
(k)    “Bad Actor Disqualification” means any “bad actor” disqualification described in Rule 506(d)(1)(i) through (viii) under the Securities Act.
(l)    The term “Commission” means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.
(m)    The term “Common Stock” means the Company’s Common Stock, par value US $0.001 each.
(n)    The term “Company Covered Person” means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1).

23

(o)    The term “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any similar federal rule or statute and the miles and regulations of the Commission thereunder, all as the same shall be in effect at the time.
(p)    The term “Founders” means each of:  Oded Comay; Doron Shikmoni; Oded Amir; Dror Comay; Yehezkel Yeshurun; and Noga Alon.
(q)    The term “Holder” means any person owning Preferred Registrable Securities or any assignee thereof in accordance with Section 1.10 hereof.
(r)    The term “Initiating Holders” means holders of a majority of the outstanding Preferred Registrable Securities.
(s)    The term “Investors” means the A Investors, the B Investors, the C Investors, the D Investors, the E Investors, the E-1 Investors, the F Investors and the G Investors, provided, however, that the E-1 Investors shall not be deemed Investors for the purposes of Subsection 1.2 and Sections 2, 3, 7, or 8.
(t)    The term “IPO” means the first public offering of the Common Stock by the Company pursuant to a bona fide, firm commitment underwriting pursuant to a registration statement under the Securities Act, or any equivalent law of another jurisdiction.
(u)    The term “Person” means any individual, corporation, partnership, joint venture, association, joint-stock company, limited liability company, trust or unincorporated organization.
(v)    The term “Permitted Transferee” means (i) with respect to each stockholder that is a party hereto (A) the spouse or member of such stockholder’s immediate family, or (B) a custodian, trustee (including a trustee of a voting trust), executor, or other fiduciary for the account of such stockholder’s spouse or members of such stockholder’s immediate family, or a trust for such stockholder’s own self, or a charitable remainder trust, or (C) a wholly owned entity (company, partnership and the like) of such stockholder, (ii) with respect to a stockholder which is a general or limited partnership or limited liability company, (A) its partners or members (including a retired partner or member of such partnership or limited liability company who retires after the date hereof, or the estate of any such partner or member or retired partner or member, the spouse of such partner or member, or the siblings, lineal descendants or ancestors of such partner or member or his or her spouse) and affiliated entities managed by the same management company or managing general partner or by an entity which controls, is controlled by, or is under common control with, such management company or managing general partner, and (B) any person who is Transferred equity securities in connection with the liquidation, dissolution or winding up of such partnership or limited liability company, or (iii) with respect to Amadeus or its trustee, custodian or nominee:  (a) any trustee or custodian for Amadeus or any beneficiary for whom Amadeus is the trustee or custodian; or (b) any general partner or manager in Amadeus; provided that each such transferee or assignee specified above, prior to the completion of the sale, transfer, or assignment shall have executed documents assuming the obligations of such transferring stockholder under this Agreement and any ancillary documents or other agreement to which such stockholder and the Company are 

24

parties with respect to the transferred securities, as well as such other documents as may be reasonably requested by the Company to ensure compliance with any applicable securities laws or regulations.  Additionally, and without derogating from anything hereinabove, it is acknowledged that securities of the Company currently held or acquired in the future by Pitango Principals Fund III (USA) LP (“Pitango Principals Fund” and “Pitango Principals’ Holdings”, respectively) are or may be subject to a charge in favor of Bank Leumi Le’Israel BM or any of its affiliates (together, the “Bank”), and that the creation by Pitango Principals Fund of a charge in favor of the Bank on Pitango Principals’ Holdings shall not be subject to the right of first refusal or any other restrictions on Transfers of shares contained herein, and that, for purposes of creation of such charge, the Bank is deemed a Permitted Transferee of Pitango Principals Fund (and vice versa in case of removal of the charge).  However, any Transfer of ownership in Pitango Principals’ Holdings as part of a realization of the said charge to a person or entity (including the Bank itself) which is not Pitango Principals Fund or any of its Permitted Transferees, shall be subject to the right of first refusal and any other restrictions on Transfers of shares applicable hereunder to a Transfer of shares.
(w)    The term “Pitango” means Pitango JP Morgan Fund (III) USA L.P., Pitango Chase Fund III (USA) L.P., Pitango Venture Capital Fund III (USA) L.P., Pitango Venture Capital Fund III (USA) Non-Q L.P., Pitango Venture Capital Fund III (Israeli Investors) L.P., Pitango Venture Capital Fund III Trusts 2000 Ltd., Pitango Principals Fund III (USA) LP., and Pitango Parallel Investor Fund III (USA) L.P. and their Permitted Transferees.
(x)    The term “Preferred Registrable Securities” means (i) all shares of Common Stock issued or issuable upon conversion of the Preferred Stock issued by the Company, (ii) all shares of Common Stock, and/or all shares of Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company, existing on the date hereof or acquired by the Investors after the date hereof, (iii) all shares of Common Stock issued by the Company in respect of such shares of Common Stock referred to in clauses (i)-(ii) above, including bonus shares, share dividends or other distribution and (iv) the shares of Common Stock issuable upon conversion of the shares issuable upon exercise of the Warrants to Purchase Stock, dated as of October 24, 2012, issued to Gold Hill Capital 2008, L.P. and Silicon Valley Bank, provided however, that such shares of stock shall not be deemed Preferred Registrable Securities for the purposes of Section 1.2 of the Agreement.   As to any particular Preferred Registrable Securities, such securities shall cease to be Preferred Registrable Securities when (x) they have been distributed to the public pursuant to an offering registered under the Securities Act or sold to the public through a broker, dealer or market maker in compliance with Rule 144 under the Securities Act (or any similar rule then in force), (y) have been transferred in a transaction in which the transferor’s rights under this Agreement are not properly assigned, or (z) all such shares could be distributed by the holder thereof pursuant to Rule 144 (in accordance with applicable law) within three (3) months without the registration of such shares.
(y)    The term “Preferred Stock” means the Company’s Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock, the Series D Preferred Stock, Series E Preferred Stock, Series E-1 Preferred Stock, Series F Preferred Stock and Series G Preferred Stock. 

25

(z)    The term “Preferred Stockholder” means holders of Preferred Stock.
(aa)    The term “register,” “registered,” and “registration” refer to a registration effected by preparing and tiling a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document.
(bb)    The term “Rule 144” shall mean Rule 144 under the Securities Act or any successor or similar rule as may be enacted by the Commission from time to time, but shall not include Rule 144A.
(cc)    The term “Securities Act” means the Securities Act of 1933, as amended, or any similar federal rule or statute and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.
(dd)    “Selling Expenses” shall mean all customary underwriting fees and discounts, selling commissions and stock transfer taxes applicable to the shares registered by the Holders (excluding the reasonable fees and disbursements of one counsel selected by the majority of the Selling Stockholders which shall be borne by the Company in accordance with section 1.6(a), which shall not exceed $50,000).
(ee)    The term “Series A Preferred Stock” means the Company’s Series A Preferred Stock, par value US $0.001 each.
(ff)    The term “Series B Preferred Stock” means the Company’s Series B Preferred Stock, par value US $0.001 each.
(gg)    The term “Series C Preferred Stock” means the Company’s Series C Preferred Stock, par value US $0.001 each.
(hh)    The term “Series D Preferred Stock” means the Company’s Series D Preferred Stock, par value US $0.001 each and the Company’s Series D 1 Preferred Stock, par value US $0.001 each.
(ii)    The term “Series E Preferred Stock” means the Company’s Series E Preferred Stock, par value US $0.001 each.
(jj)    The term “Series E-1 Preferred Stock” means the Company’s Series E-1 Preferred Stock, par value US $0.001 each.
(kk)    The term “Series E-2 Preferred Stock” means the Company’s Series E-2 Preferred Stock, par value US $0.001 each.
(ll)    The term “Series F Preferred Stock” means the Company’s Series F Preferred Stock, par value US $0.001 each.

26

(mm)    The term “Series G Preferred Stock” means the Company’s Series G Preferred Stock, par value US $0.001 each.
(nn)    The term “Wellington” shall mean Wellington Management Company LLP and any successor or affiliated registered investment advisor to the Wellington Investors.
(oo)    The term “Wellington Investors” shall mean any Investors advised or subadvised by Wellington or one of its affiliates as of the date hereof.
11.    Miscellaneous.
11.1    Entire Agreement, Amendments and Waivers.  This Agreement constitutes the full and entire understanding and agreement between the parties with regard to the subject matters hereof and thereof, and abolishes and supersedes all prior agreements between the parties hereof with regard to such subject matters, including without limitation, the Prior Rights Agreement.  Except as otherwise provided herein, the provisions of this Agreement may be amended or waived only upon the prior written consent of the Company and the holders of at least a majority of the Preferred Stock voting together as a single class on an as converted basis.  Notwithstanding the foregoing, (i) if any amendment, termination or waiver expressly by its terms or by reference to a specific Holder or characteristics of a specific Holder  applies to the rights and obligations of such specific Holder in a manner that is different and adverse, in any material respect, from the manner in which such amendment, termination or waiver applies to the rights and obligations of other Holders, the consent of such specific Holder shall also be required for such amendment, termination or waiver, (ii) in the event that any amendment hereof adversely affects the rights of the Founders in a manner disproportionate to any adverse effect such amendment or waiver would have on the rights of the Investors, such amendment shall also require the consent of the holders of a majority of the shares of Common Stock then outstanding and held by the Founders and (iii) Sections 1.4, 2.1(a)(i)-(ii), 2.5, 7(c), 9(b) and 11.11 shall not be modified, supplemented, amended or waived, in whole or in part, in a manner that adversely affects the Wellington Investors, without the prior written consent of the Wellington Investors holding a majority of the Series G Preferred Stock held by all Wellington Investors.  Any amendment or waiver effected in accordance with this paragraph shall be binding upon each Holder, each future holder of all such Preferred Registrable Securities, the Founders and the Company.
11.2    Successors and Assigns.  All covenants and agreements in this Agreement by or on behalf of any of the parties hereto shall bind and inure to the benefit of the respective successors and assigns of the parties hereto whether so expressed or not.  Other than as set forth in Section 1.10 above, none of the Investors’ rights, privileges, or obligations set forth in, arising under, or created by this Agreement may be assigned or transferred without the prior consent in writing of the Company, except that an Investor may assign or transfer such rights to Permitted Transferee without such consent.  No assignment or transfer shall become effective unless each such transferee has signed a joinder to this Agreement and has provided the Company with a confirmation in writing that it is bound by all terms and conditions, of this Agreement and all other agreements of the stockholders of the Company, as if it were an original party to all such agreements.

27

11.3    Severability.  Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.
11.4    Counterparts; Facsimile Transmission.  This Agreement may be executed simultaneously in two or more counterparts, any one of which need not contain the signatures of more than one party, but all such counterparts taken together shall constitute one and the same Agreement.  Each party to this Agreement agrees that it will be bound by its own telecopied signature and that it accepts the telecopied signature of each other party to this Agreement.
11.5    Descriptive Headings.  The descriptive headings of this Agreement are inserted for convenience only and do not constitute a part of this Agreement.
11.6    Governing Law.  This Agreement shall be governed by and construed in accordance with the domestic laws of the State of Delaware, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the Slate of Delaware.
11.7    Notices.  All notices, demands or other communications to be given or delivered under or by reason of the provisions of this Agreement shall be in writing and shall be deemed to have been given upon the earlier of actual receipt or (i) personal delivery to the party notified; (ii) when sent, if sent by electronic mail or facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of receipt.  All such notices, demands and other communications shall be sent to each Founders or Investors to the addresses indicated on Schedule A or Schedule B, respectively, and in case of the Company, to the address of its principal office to the attention of the Chief Executive Officer or to such other address or to the attention of such other Person as the recipient party has specified by prior written notice given in accordance with this Section 11.7. to the sending party. 
11.8    Additional Investors.  Notwithstanding Section 11.1, no consent shall be necessary to add Additional Investors as signatories to this Agreement, provided that any such Investor is an Additional Investor as defined in Section 1.3 of the G Purchase Agreement.
11.9    Aggregation of Stock.  Except as otherwise specifically set forth herein, all shares of Preferred Registrable Securities held or acquired by affiliated entities (including affiliated venture capital funds) or persons shall be aggregated together for the purpose of determining the availability of any rights or obligations under this Agreement.  Without limiting the generality of the foregoing, with respect to any Investor that is a Holder and that is a partnership or corporation, the partners, retired partners, shareholders and affiliates of such Investor, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the 

28

foregoing persons shall be deemed to be a single “Investor” and shall be aggregated together for any purpose hereunder.
11.10    Waiver of Right of First Offer and Notice.  The undersigned holders of at least a majority of the Preferred Stock of the Company unconditionally waive all rights to notice and preemptive rights set forth in Section 3 of the Prior Rights Agreement and any rights set forth herein with respect to the issuance of the Series G Preferred Stock issued pursuant to the G Purchase Agreement and any shares of Common Stock issued upon conversion thereof.
11.11    Acknowledgement.  The Company acknowledges that Wellington Management Company LLP is in the business of providing investment management services for its investment advisory clients and therefore, reviews the financial information, business plans and proprietary and other information of many enterprises, including enterprises that may have products or services which compete directly or indirectly with those of the Company.  Subject to Section 9 hereof, nothing in this Agreement shall preclude or in any way restrict Wellington Management Company LLP from investing on behalf of its investment advisory clients, whether or not such enterprise has products or services which compete with those of the Company.  Subject to Section 9 hereof, the Company further acknowledges that Wellington Management Company LLP, on behalf of certain of its investment advisory clients, trades in securities in the public markets and that Wellington Management Company LLP’s access to the Company’s confidential information shall not preclude or in any way restrict Wellington Management Company LLP’s ability to trade securities in the public markets on behalf of its investment advisory clients, nor shall the access to such confidential information by any investment advisory client preclude or in any way restrict such investment advisory client’s ability to trade securities in the public markets.  For purposes of clarity, the term “investment advisory clients” includes, without limitation, the Wellington Investors.
[THIS SPACE INTENTIONALLY LEFT BLANK]

29

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above. 
Company:
	
		
	FORESCOUT TECHNOLOGIES, INC.

	

By:
	/s/ Michael DeCesare

	

Name:  
	Michael DeCesare

	

Title:
	Chief Executive Officer

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above. 
Founder:
	
		
	DORON SHIKMONI

	

By:
	/s/ Doron Shikmoni

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above. 
Founder:
	
		
	ODED COMAY

	

By:
	/s/ Oded Comay

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above. 
Founder:
	
		
	YEHEZKEL YESHURUN

	

By:
	/s/ Yehezkel Yeshurun

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

Hartford Global Capital Appreciation Fund

By:    Wellington Management Company LLP,
as investment adviser
	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

Global Multi-Strategy Fund

By:    Wellington Management Company LLP,
as investment adviser

	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

The Hartford Growth Opportunities Fund

By:    Wellington Management Company LLP,
as investment adviser

	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

The Hartford Capital Appreciation Fund

By:    Wellington Management Company LLP,
as investment adviser

	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

Hartford Growth Opportunities HLS Fund

By:    Wellington Management Company LLP,
as investment adviser

	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

Hadley Harbor Master Investors (Cayman) L.P.

By:    Wellington Management Company LLP,
as investment adviser

	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

Ithan Creek Master Investors (Cayman) L.P.

By:    Wellington Management Company LLP,
as investment adviser

	
			
	By:
	/s/ Steven M. Hoffman

	 
	Name:
	Steven M. Hoffman

	 
	Title:
	Managing Director & Counsel

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
					
	/s/ Richard Anton
	 
	/s/ Richard Anton

	AMADEUS II ‘A’

	 
	AMADEUS II ‘B’

	By:
	Amadeus Capital Partners Limited
 
its Manager

	 
	By:
	Amadeus Capital Partners Limited 
its Manager

	

Name:  
	Richard Anton
	 
	

Name:  
	Richard Anton

	

Title:
	Partner
	 
	

Title:
	Partner

	

/s/ Richard Anton
	 
	/s/ Richard Anton

	AMADEUS II ‘C’

	 
	AMADEUS II ‘D’ GMBH & CO KG

	By:
	Amadeus Capital Partners Limited
its Manager

	 
	By:
	Amadeus Capital Partners Limited 
its Manager

	

Name:  
	Richard Anton
	 
	

Name:  
	Richard Anton

	

Title:
	Partner
	 
	

Title:
	Partner

	

/s/ Richard Anton
	 
	/s/ Richard Anton

	AMADEUS II AFFILIATES FUND LP

	 
	AMADEUS EI L.P.

	By:
	Amadeus Capital Partners Limited
its Manager

	 
	By:
	Amadeus Capital Partners Limited
its Manager 

	

Name:  
	Richard Anton
	 
	

Name:  
	Richard Anton

	

Title:
	Partner
	 
	

Title:
	Partner

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
					
	/s/ Richard Anton
	 
	/s/ Richard Anton

	AMADEUS IV VELOCITY FUND L.P.

	 
	AMADEUS EII L.P.

	By:
	Amadeus Capital Partners Limited
its Manager

	 
	By:
	Amadeus Capital Partners Limited 
its Manager

	

Name:  
	Richard Anton
	 
	

Name:  
	Richard Anton

	

Title:
	Partner
	 
	

Title:
	Partner

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
					
	/s/ Tracy L. Sedlock
	 
	/s/ Tracy L. Sedlock

	ACCEL INTERNET FUND IV L.P.

	 
	ACCEL VIII L.P.

	By:
	Accel VIII Associates L.L.C.
its General Partner 

	 
	By:
	Accel VIII Associates L.L.C.
its General Partner 

	

Name:  
	Tracy L. Sedlock
	 
	

Name:  
	Tracy L. Sedlock

	

Title:
	Attorney-In-Fact
	 
	

Title:
	Attorney-In-Fact

	

	 
	 
	 

	 
	 
	 
	 

	ACCEL INVESTORS 2000 L.L.C.

	 
	 
	 

	

By:
	/s/ Tracy L. Sedlock
	 
	 
	 

	

Name:  
	Tracy L. Sedlock
	 
	 
	 

	

Title:
	Attorney-In-Fact
	 
	 
	 

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
					
	/s/ Michael B. Gordon
	 
	/s/ Michael B. Gordon

	MERITECH CAPITAL PARTNERS II L.P.
	 
	MERITECH CAPITAL AFFILIATES II L.P.

	By:
	Meritech Capital Associates II L.L.C.
its General Partner
	 
	By:
	Meritech Capital Associates II L.L.C.
its General Partner

	By:
	Meritech Management Associates II L.L.C.
a managing member
	 
	By:
	Meritech Management Associates II L.L.C.
a managing member

	

Name:  
	Michael B. Gordon
	 
	

Name:  
	Michael B. Gordon

	

Title:
	A Managing Member
	 
	

Title:
	A Managing Member

	
		
	/s/ Michael B. Gordon

	MCP ENTREPRENEUR PARTNERS II L.P.

	By:
	Meritech Capital Associates II L.L.C.
its General Partner

	By:
	Meritech Management Associates II L.L.C.
a managing member

	

Name:  
	Michael B. Gordon

	

Title:
	A Managing Member

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
							
	 
	 
	 
	 
	 

	PITANGO VENTURE CAPITAL FUND III (USA) L.P.

	 
	PITANGO VENTURE CAPITAL FUND III (USA) NON-Q L.P.

	By:
	/s/ Zeev Binman
	/s/ Bruce Crocker
	 
	By:
	/s/ Zeev Binman
	/s/ Bruce Crocker

	Name:  
	Zeev Binman
	Bruce Crocker
	 
	Name:  
	Zeev Binman
	Bruce Crocker

	Title:
	 
	 
	 
	Title:
	 
	 

	

	 
	 
	 
	 

	PITANGO VENTURE CAPITAL FUND III (ISRAELI INVESTORS) L.P.
	 
	PITANGO PRINCIPALS FUND III (USA) L.P.

	By:
	/s/ Zeev Binman
	/s/ Bruce Crocker
	 
	By:
	/s/ Zeev Binman
	/s/ Bruce Crocker

	Name:
	Zeev Binman
	Bruce Crocker
	 
	Name:  
	Zeev Binman
	Bruce Crocker

	Title:
	 
	 
	 
	Title:
	 
	 

	

	 
	 
	 
	 

	PITANGO PARALLEL INVESTOR FUND III (USA) L.P.
	 
	PITANGO VENTURE CAPITAL FUND III TRUSTS 2000 LTD.

	By:
	/s/ Zeev Binman
	/s/ Bruce Crocker
	 
	By:
	/s/ Zeev Binman
	/s/ Bruce Crocker

	Name:
	Zeev Binman
	Bruce Crocker
	 
	Name: 
	Zeev Binman
	Bruce Crocker

	Title:
	 
	 
	 
	Title:
	 
	 

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
							
	 
	 
	 
	 
	 

	VINTAGE VENTURE PARTNERS III (CAYMAN) L.P.
By: Its general partner Vintage Ventures III L.P.
By: Its general partner Vintage Ventures Fund 3 Ltd.
	 
	VINTAGE VENTURE PARTNERS III (ISRAEL) L.P.
By: Its general partner Vintage Ventures III L.P.
By: Its general partner Vintage Ventures Fund 3 Ltd.

	

By:
	/s/ Alan Feld
	/s/ Hagai Goldhirsh
	 
	

By:
	/s/ Alan Feld
	/s/ Hagai Goldhirsh

	

Name:  
	Alan Feld
	Hagai Goldhirsh
	 
	

Name:  
	Alan Feld
	Hagai Goldhirsh

	

Title:
	CEO
	CFO
	 
	

Title:
	CEO
	CFO

	

	 
	 
	 
	 

	VINTAGE INVESTMENT PARTNERS V (CAYMAN) L.P.
By: Its general partner Vintage Investments 5 L.P.
By: Its general partner Vintage Fund 5 Ltd.
	 
	VINTAGE INVESTMENT PARTNERS V (ISRAEL) L.P.
By: Its general partner Vintage Investments 5 L.P.
By: Its general partner Vintage Fund 5 Ltd.

	

By:
	/s/ Alan Feld
	/s/ Hagai Goldhirsh
	 
	

By:
	/s/ Alan Feld
	/s/ Hagai Goldhirsh

	

Name:  
	Alan Feld
	Hagai Goldhirsh
	 
	

Name:  
	Alan Feld
	Hagai Goldhirsh

	

Title:
	CEO
	CFO
	 
	

Title:
	CEO
	CFO

	

	 
	 
	 
	 

	VINTAGE INVESTMENT PARTNERS VI (ISRAEL) L.P.
By: Its general partner Vintage Investments VI (Israel) L.P.
By: Its general partner Vintage Fund 6 Ltd.
	 
	VINTAGE INVESTMENT PARTNERS VI (CAYMAN) L.P.
By: Its general partner Vintage Investments VI (Cayman) L.P.
By: Its general partner Vintage Fund 6 Ltd.

	

By:
	/s/ Alan Feld
	/s/ Hagai Goldhirsh
	 
	

By:
	/s/ Alan Feld
	/s/ Hagai Goldhirsh

	

Name:
	Alan Feld
	Hagai Goldhirsh
	 
	

Name: 
	Alan Feld
	Hagai Goldhirsh

	

Title:
	CEO
	CFO
	 
	

Title:
	CEO
	CFO

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
		
	/s/ Rob Helm

	GOLD HILL CAPITAL 2008, LP

	

By:
	Gold Hill Capital 2008, LLC, General Partner

	

Name:
	Rob Helm

	

Title:
	Partner

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.
Investor:
	
	
	/s/ Benny Bergman

	Benny Bergman

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

	
		
	/s/ Benny Bergman

	B.C.S. GROWTH FUND (ISRAEL) L.P.

	

By:
	 

	

Name:
	Benny Bergman

	

Title:
	CEO of G. M.

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

CROSS CREEK CAPITAL II, L.P.
	
		
	By:
	Cross Creek Capital II GP, L.P.

	 
	Its Sole General Partner

	
		
	By:
	/s/ Tyler Christenson

	Name:
	Tyler Christenson

	Title:
	Managing Director

CROSS CREEK CAPITAL PARTNERS III, L.P.
	
		
	By:
	Cross Creek Capital Partners III GP, LLC

	 
	Its Sole General Partner

	
		
	By:
	/s/ Tyler Christenson

	Name:
	Tyler Christenson

	Title:
	Managing Director

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

ASPECT VENTURES,  L.P.
	
		
	By:
	/s/ Theresia Gouw

	Name:
	Theresia Gouw

	Title:
	Managing Member

ASPECT VENTURES I-A,  L.P.
	
		
	By:
	/s/ Theresia Gouw

	Name:
	Theresia Gouw

	Title:
	Managing Member

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

WASATCH FUNDS TRUST
for Wasatch Small Cap Growth Fund 

	
		
	By:
	Wasatch Advisors, Inc.

	Its:
	Investment Adviser

	 

	By:
	/s/ Daniel Thurber

	Name:
	Daniel Thurber

	Its:
	Vice President

	 
	 

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

Investor:
	
					
	/s/ Tom Leighton
	 
	/s/ Tom Leighton

	Tom Leighton
	 
	F. THOMAS LEIGHTON & BONNIE B LEIGHTON REVOCABLE TRUST DTD 11/3/1999

	 
	 
	 
	

By:
	 

	 
	 
	 
	

Name:  
	Tom Leighton

	 
	 
	 
	

Title:
	Trustee

	 
	 
	 

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

IN WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date first written above.

RED BEARD HOLDINGS, LLC
	
		
	By:
	/s/ Vincent C. Smith

	Name:
	Vincent C. Smith

	Its:
	Manager

SIGNATURE PAGE TO A&R INVESTORS’ RIGHTS AGREEMENT

Schedule A 

Founders:
	
		
	Name
	Address

	Oded Comay
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

	Doron Shikmoni
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

	Oded Amir
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

	Dror Comay
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

	Yehezkel Yeshurun
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

	Noga Alon
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

Schedule B

Investors:
	
		
	Part II
A Investors
	 

	B.C.S. Growth Fund (Israel) L.P
	3 Daniel Frisch Street,
Tel Aviv, Israel

	Benny Bergman
	c/o B.C.S. Growth Fund (Israel) L.P.
3 Daniel Frisch Street,
Tel Aviv, Israel

	Yaad Consulting & Management Services 
(1995) Ltd.
	c/o SFK Ltd.
21 Ha’arba Street
Tel Aviv, Israel

	Dan Caspi
	c/o B.C.S. Growth Fund (Israel) L.P.
3 Daniel Frisch Street,
Tel Aviv, Israel

	Adigar Technologies Ltd.
	20 Lincoln Street,
Tel Aviv, Israel 
Attn: Zvika Yochman

	Yeoshua Agassi

	36 Belinson Street,
Kiryat Uno, Israel

	Shimon Lahat
	108 Jerusalem Boulevard
Ramat Gan, Israel

	Avantorin Investments Ltd.
	9 Ehad Ha’am Street,
Tel Aviv, Israel
Attn: Yoav Kaplan

	Yigal Arnon Hi-Tech Investments L.P.
	1 Azrieli Center,
Tel Aviv, Israel
Attn: Orly Tsioni, Adv.

	Eran Ilan
	c/o Yigal Arnon & Co.
1 Azrieli Center,
Tel Aviv, Israel

	NIR4YOU Technologies Ltd.
	c/o TIS Ltd.
2 Habarzel Street,
Tel Aviv, Israel
Attn: Itzchak Nakar

	Jacob Barshack
	6 Ori Street,
Tel Aviv, Israel

	
		
	G.M.Trust Company Ltd.
	c/o Adv. Zeev May
8 Shpinoza Street,
Tel Aviv, Israel

	Shimon Ullman
	Weizmann Institute
POB 26, Rehovot 76100
Israel

	Linani Ltd.
	c/o Ness Technologies Ltd. and Yaron Polak
98 Wingate Street
Herzlia 46752, Israel

	Roy Zisapel
	c/o SFK Ltd.
21 Ha’arba Street
Tel Aviv, Israel

	Tom Leighton
	15 Charlesden Pk
Newtonville, MA 02460-2207
Email: ftl@akamai.com

	The Estate of Danny Lewin
	c/o Hale & Dorr LLP
60 State Street
Boston, MA, 02109
USA
Attn: A. Silvana Giner, Adv.

	Yoav Shoham
	c/o Forescout Technologies Ltd.
24 Raoul Wallenberg St.
Entrance D, 3rd floor
Tel Aviv, 6971924, Israel

	Yael Shrem
	c/o SFK Ltd.
21 Ha’arba Street
Tel Aviv, Israel

	 
	 

	B Investors
	 

	Accel VIII L.P.

	428 University Avenue
Palo Alto, CA 94301

	Accel Internet Fund IV L.P.
	428 University Avenue
Palo Alto, CA 94301

	Accel Investors 2000 L.L.C.
	428 University Avenue
Palo Alto, CA 94301
Attn: Theresia Ranzetta

	
		
	Pitango Venture Capital Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (USA) Non-Q
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (Israeli Investors)
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango JP Morgan Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III Trusts 2000 Ltd.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel

	Pitango Principals Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	B.C.S. Growth Fund (Israel) L.P
	3 Daniel Frisch Street,
Tel Aviv, Israel

	Benny Bergman
	c/o B.C.S. Growth Fund (Israel) L.P.
3 Daniel Frisch Street,
Tel Aviv, Israel

	Yaad Consulting & Management Services 
(1995) Ltd.
	c/o SFK Ltd.
21 Ha’arba Street
Tel Aviv, Israel

	Dan Caspi
	c/o B.C.S. Growth Fund (Israel) L.P.
3 Daniel Frisch Street,
Tel Aviv, Israel

	Adigar Technologies Ltd.
	20 Lincoln Street,
Tel Aviv, Israel 
Attn: Zvika Yochman

	Yigal Arnon Hi-Tech Investments L.P.
	1 Azrieli Center,
Tel Aviv, Israel
Attn: Orly Tsioni, Adv.

	
		
	Eran Ilan Investments Ltd.
	c/o Yigal Arnon & Co.
1 Azrieli Center,
Tel Aviv, Israel

	Jacob Barshack
	6 Ori Street,
Tel Aviv, Israel

	Shimon Ullman
	Weizmann Institute
POB 26, Rehovot 76100
Israel

	Linani Ltd.
	c/o Ness Technologies Ltd.
Kiryat Atidim, Building 4,
Tel Aviv, Israel

	Shrem Fudim Kelner-Trust Company Ltd.
	21 Ha’arba Street
Tel Aviv, Israel

	Shrem, Fudim Kelner Founder Group II, LP
	21 Ha’arba Street
Tel Aviv, Israel

	Canada Israel Opportunity Fund III LP
	21 Ha’arba Street
Tel Aviv, Israel

	Shrem, Fudim, Kelner & Co. Ltd.
	21 Ha’arba Street
Tel Aviv, Israel

	Arko Holdings Ltd.
	21 Ha’arba Street
Tel Aviv, Israel

	Arko Technological Holdings LP
	21 Ha’arba Street
Tel Aviv, Israel

	Vintage Venture Partners III (Cayman) LP
	C/o Vintage Investment Partners
Ackerstein Towers, Bldg D 10th Floor
12 Abba Eban Avenue
Herzliya Pituach, 46120 Israel

	Vintage Venture Partners III (Israel) LP
	C/o Vintage Investment Partners
Ackerstein Towers, Bldg D 10th Floor
12 Abba Eban Avenue
Herzliya Pituach, 46120 Israel

	 
	 

	C Investors
	 

	Meritech Capital Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	
		
	Meritech Capital Affiliates II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	MCP Entrepreneur Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	Accel VIII L.P.

	428 University Avenue
Palo Alto, CA 94301

	Accel Internet Fund IV L.P.
	428 University Avenue
Palo Alto, CA 94301

	Accel Investors 2000 L.L.C.
	428 University Avenue
Palo Alto, CA 94301

	Pitango Venture Capital Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (USA) Non-Q
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (Israeli Investors)
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III Trusts 2000 Ltd.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel

	Pitango Principals Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Technology Ventures I Venture Capital Investment Limited Partnership

	18F Itochu Building
5-1, Kita-Aoyama 2-chome
Minato-ku, Tokyo 107-0061
JAPAN

	Itochu Corporation

	5-1, Kita-Aoyama 2-chome,
Minato-ku, Tokyo, 107-8077
Japan

	D Investors
	 

	
		
	Amadeus II ‘A’
Amadeus II ‘B’
Amadeus II ‘C’

	50 Lothian Road, Edinburgh, EH3 9BV 
Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge CB3 0RN
Fax:44-1223-707070
Attn: Richard Anton
e-mail: Richard.anton@amadeuscapital.com

	Amadeus II ‘D’ GmbH & Co KG

	c/o VCM Venture Capital Management und Beteiligungsgesellschaft mbH, Max-Joseph-Strasse 7, 80333 Munich 
Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge CB3 0RN
Fax:44-1223-707070
Attn: Richard Anton
e-mail: Richard.anton@amadeuscapital.com

	Amadeus II Affiliates Fund L.P.
	c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801, USA 
Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge CB3 0RN
Fax:44-1223-707070
Attn: Richard Anton
e-mail: Richard.anton@amadeuscapital.com

	Meritech Capital Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	Meritech Capital Affiliates II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	MCP Entrepreneur Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	Accel VIII L.P.

	428 University Avenue
Palo Alto, CA 94301

	Accel Internet Fund IV L.P.
	428 University Avenue
Palo Alto, CA 94301

	Accel Investors 2000 L.L.C.
	428 University Avenue
Palo Alto, CA 94301

	
		
	Pitango Venture Capital Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (USA) Non-Q
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (Israeli Investors)
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango JP Morgan Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III Trusts 2000 Ltd.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel

	Pitango Principals Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Linani Ltd.
	c/o Ness Technologies Ltd.
Kiryat Atidim, Building 4,
Tel Aviv, Israel

	Technology Ventures I Venture Capital 
Investment Limited Partnership

	18F Itochu Building
5-1, Kita-Aoyama 2-chome
Minato-ku, Tokyo 107-0061
JAPAN

	B.C.S. Growth Fund (Israel) L.P
	3 Daniel Frisch Street,
Tel Aviv, Israel

	Benny Bergman
	c/o B.C.S. Growth Fund (Israel) L.P.
3 Daniel Frisch Street,
Tel Aviv, Israel

	Yaad Consulting & Management Services 
(1995) Ltd.
	c/o SFK Ltd.
21 Ha’arba Street
Tel Aviv, Israel

	Dan Caspi
	c/o B.C.S. Growth Fund (Israel) L.P.
3 Daniel Frisch Street,
Tel Aviv, Israel

	
		
	Adigar Technologies Ltd.
	20 Lincoln Street,
Tel Aviv, Israel 
Attn: Zvika Yochman

	Yigal Arnon Hi-Tech Investments L.P.
	1 Azrieli Center,
Tel Aviv, Israel
Attn: Orly Tsioni, Adv.

	Eran Ilan Investments Ltd.
	c/o Yigal Arnon & Co.
1 Azrieli Center,
Tel Aviv, Israel

	Jacob Barshack
	6 Ori Street,
Tel Aviv, Israel

	Shimon Ullman
	Weizmann Institute
POB 26, Rehovot 76100
Israel

	Shrem, Fudim Kelner Founder Group II – 
Annex Fund LP
	21 Ha’arba Street
Tel Aviv, Israel

	Canada Israel Opportunity Fund III LP
	21 Ha’arba Street
Tel Aviv, Israel

	Shrem, Fudim, Kelner & Co. Ltd.
	21 Ha’arba Street
Tel Aviv, Israel

	Arko Holdings Ltd.
	21 Ha’arba Street
Tel Aviv, Israel

	Arko Technological Holdings LP
	21 Ha’arba Street
Tel Aviv, Israel

	 
	 

	E Investors
	 

	Amadeus II ‘A’
Amadeus II ‘B’
Amadeus II ‘C’

	50 Lothian Road, Edinburgh, EH3 9BV 
Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge CB3 0RN
Fax:44-1223-707070
Attn: Richard Anton
e-mail: Richard.anton@amadeuscapital.com

	
		
	Amadeus II ‘D’ GmbH & Co KG

	c/o VCM Venture Capital Management und Beteiligungsgesellschaft mbH, Max-Joseph-Strasse 7, 80333 Munich 
Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge CB3 0RN
Fax:44-1223-707070
Attn: Richard Anton
e-mail: Richard.anton@amadeuscapital.com

	Amadeus II Affiliates Fund L.P.
	c/o The Corporation Trust Company, 1209 Orange Street, Wilmington, New Castle County, Delaware 19801, USA 
Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge CB3 0RN
Fax:44-1223-707070
Attn: Richard Anton
e-mail: Richard.anton@amadeuscapital.com

	Meritech Capital Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	Meritech Capital Affiliates II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	MCP Entrepreneur Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA  94301

	Accel VIII L.P.

	428 University Avenue
Palo Alto, CA 94301

	Accel Internet Fund IV L.P.
	428 University Avenue
Palo Alto, CA 94301

	Accel Investors 2000 L.L.C.
	428 University Avenue
Palo Alto, CA 94301

	Pitango Venture Capital Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (Israeli Investors)
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	
		
	Pitango Parallel Investor Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III (USA) Non-Q
L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Pitango Venture Capital Fund III Trusts 2000 Ltd.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel

	Pitango Principals Fund III (USA) L.P.
	11 HaMenofim Street
Building B
Herzeliya 46725, Israel 

	Linani Ltd
	c/o Ness Technologies Ltd.
Kiryat Atidim, Building 4,
Tel Aviv, Israel

	E-1 Investors
	 

	Silicon Valley Bank
	Attn: Treasury Department
3003 Tasman Drive, HC 215
Santa Clara, CA 95054
Email: deriviatives@svb.com

	Gold Hill Capital 2008, L.P.
	One Almaden Blvd., Suite 630
San Jose, CA 95113
Attn: Glenn Marasigan
Email: gmarasigan@goldhillcapital.com

F Investors
	
		
	Name
	Address

	Amadeus IV Velocity Fund LP
	Acting by its manager Amadeus Capital Partners Limited having its registered office at Mount Pleasant House, 2 Mount Pleasant, Cambridge 
CB3 0RN 
Fax:44-1223-707070 
Attn: Richard Anton 
e-mail: 
Richard.anton@amadeuscapital.com

	Amadeus EII LP

	Meritech Capital Partners II L.P.
	245 Lytton Ave, Suite 125
Palo Alto, CA 94301

	Meritech Capital Affiliates II L.P.

	MCP Entrepreneur Partners II L.P.

	
		
	Name
	Address

	Accel VIII L.P.
	428 University Avenue 
Palo Alto, CA 94301

	Accel Internet Fund IV L.P.

	Accel Investors 2000 L.L.C

	Pitango Venture Capital Fund III (USA) L.P.
	11 HaMenofim Street 
Building B 
Herzliya 46725, Israel

	Pitango Venture Capital Fund III (USA) Non-Q L.P.

	Pitango Venture Capital Fund III (Israeli Investors) L.P.

	Pitango Principals Fund III (USA) L.P.

	Pitango Venture Capital Fund III Trusts 2000 Ltd

	Pitango Parallel Investor Fund III (USA) L.P.

	Aspect Ventures L.P. 

	560 Brannan Street
San Francisco, CA 94107
Email: tg@aspectventures.com 

	F. Thomson Leighton & Bonnie B Leighton Revocable Trust dtd 11/3/1999
	15 Charlesden Pk
Newtonville, MA 02460-2207
Email: ftl@akamai.com

	Cross Creek Capital II, L.P.
	505 Wakara Way, Suite 215
Salt Lake City, UT  84108
Attn:  Karey Barker

	Cross Creek Capital Partners III, L.P.

	NIR4YOU Technologies Ltd.
	4 Romanili Street
Tel Aviv, Israel
Attn: Izhak Nakar, CEO

	Vintage Venture Partners III (Cayman) LP
	12 Abba Eban Avenue
Ackerstein Towers 
Bldg. D, 10th Floor
Herzliya Petuach
46120 Israel

	Vintage Venture Partners III (Israel) LP

	Vintage Investment Partners V (Cayman) LP

	Vintage Investment Partners V (Israel) LP

G Investors
	
		
	Name
	Address

	Hartford Global Capital Appreciation Fund
	c/o Wellington Management Company LLP 
Attention:  Legal and Compliance Department
280 Congress Street 
Boston, Massachusetts 02210
Facsimile Number: 617-289-5699
Email address: seclaw@wellington.com

	Global Multi-Strategy Fund

	The Hartford Growth Opportunities Fund

	The Hartford Capital Appreciation Fund

	Hartford Growth Opportunities HLS Fund

	Hadley Harbor Master Investors (Cayman) L.P.

	Ithan Creek Master Investors (Cayman) L.P.

	CROSS CREEK CAPITAL II, L.P.
	505 Wakara Way, Suite 215
Salt Lake City, UT  84108
Attn:  Karey Barker
Email address: pjarman@crosscreekadvisors.com

	CROSS CREEK CAPITAL PARTNERS III, L.P.

	Wasatch Small Cap Growth Fund
	505 Wakara Way, 3rd Floor   
Salt Lake City, UT 84108
Attn: Sarah Brown/Dan Thurber
Phone: 801-533-0777
Fax: 801-983-4192
Email address: DIT@wasatchadvisors.com

	Aspect Ventures, L.P.
	560 Brannan Street
San Francisco, CA 94107
Email address: tg@aspectventures.com

	Aspect Ventures I-A, L.P.

	F. Thomson Leighton & Bonnie B Leighton Revocable Trust dtd 11/3/1999
	15 Charlesden Pk
Newtonville, MA 02460-2207
Email address: ftl@akamai.com

	Red Beard Holdings, LLC
	2560 E. Chapman Ave #173
Orange, CA 92869 
Email addresses: vinny.smith@vcsgrp.com; 
matt@tobacapital.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]